Dexmeditomidine versus Clonidine as an Adjuvant to 0.75%

Ropivacaine for Epidural Anaesthesia in Lower Abdominal and Lower Limb Surgeries in a Tertiary Care Centre: A Comparative Study by Sathesh Kumar, B M
DEXMEDITOMIDINE VERSUS CLONIDINE AS AN ADJUVANT 
TO 0.75% ROPIVACAINE
 IN  LOWER 
SURGERIES
THE TAMILNADU Dr. M.G.R MEDICAL
In partial fulfilment of the requirements for
M.D
 
 FOR EPIDURAL ANAESTHESIA
 ABDOMINAL  AND   LOWER LIMB 
 IN A TERTIARY CARE CENTRE 
A COMPARATIVE STUDY 
 
Dissertation 
Submitted to 
 UNIVERSITY
the award of the degree of 
.  ANAESTHESIOLOGY 
Branch X 
MAY 2018 
 
 
 
- 
 
 
CERTIFICATE 
 
 This is to certify that this dissertation entitled “Dexmeditomidine 
versus Clonidine as an Adjuvant to 0.75% Ropivacaine for Epidural 
Anaesthesia in Lower Abdominal and Lower Limb Surgeries in a 
Tertiary Care Centre - A Comparative Study” is a bonafide record of the 
work done by Dr. Sathesh Kumar B M, under guidance and supervision in 
the Department of Anaesthesiology during the period of her postgraduate 
study for M.D Anaesthesiology [Branch-X] from 2015-2018. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dr. Rommy Geever, MD 
[Co-guide] 
Asst. Professor 
Department of Anaesthesiology 
Sree Mookambika Institute of 
Medical Sciences 
Kulasekharam,  
Kanyakumari District: 
Tamil Nadu - 629161 
Dr. A Thavamani, MD 
[Guide] 
HOD and Professor 
Department of Anaesthesiology 
Sree Mookambika Institute of  
Medical Sciences 
Kulasekharam,  
Kanyakumari District, 
Tamil Nadu 629161 
Dr. Rema. V. Nair, M.D., D.G.O., 
Director 
Sree Mookambika Institute of Medical 
Sciences 
Kulasekharam,  
Kanyakumari District 
Tamil Nadu - 629161 
  
 
 
 
 
 
CERTIFICATE II 
 
 This is to certify that this dissertation work titled “Dexmeditomidine 
versus Clonidine as an Adjuvant to 0.75% Ropivacaine for Epidural 
Anaesthesia in Lower Abdominal and Lower Limb Surgeries in a 
Tertiary Care Centre - A Comparative Study” of the candidate                         
Dr. Sathesh Kumar B M, with registration Number 201520552 for the 
award of DOCTOR OF MEDICINE in the branch of Anaesthesiology 
[Branch-X]. I personally verified the urkund.com website for the purpose of 
plagiarism Check. I found that the uploaded thesis file contains from 
introduction to conclusion pages and result shows 6 percentage of plagiarism 
in the dissertation.  
 
 
 
Guide & Supervisor sign with Seal. 
 
 
 
 
 
DECLARATION 
 
In the following pages is presented a consolidated report of the study 
on “Dexmeditomidine versus Clonidine as an Adjuvant to 0.75% 
Ropivacaine for Epidural Anaesthesia in Lower Abdominal and Lower 
Limb Surgeries in a Tertiary Care Centre - A Comparative Study” cases 
studied and followed up by me at Sree Mookambika Institute of Medical 
Sciences, Kulasekharam from 2016-2017. This thesis is submitted to the Dr. 
M.G.R. Medical University, Chennai in partial fulfilment of the rules and 
regulations for the award of MD Degree examination in Anaesthesiology. 
 
 
 
 
Dr. Sathesh Kumar B M,  
Junior Resident  
Department of Anaesthesiology,  
Sree  Mookambika Institute of 
Medical Sciences,  
Kulasekharam,  
Kanyakumari District. 
Tamil Nadu 629161. 
 
 
Date:  
Place: 
  
ACKNOWLEDGEMENT 
 
I wish to express my sincere thanks to Dr. Velayutham Nair, Chairman 
and Dr. Rema V. Nair, Director of Sree Mookambika Institute of Medical 
Sciences for having permitted me to utilize the facilities of the hospital for the 
conduct of the study.   
My heartfelt gratitude to Prof. Dr. A. Thavamani, Professor and Head, 
Department of Anaesthesiology, Sree Mookambika Institute of Medical 
Sciences and Hospital for his motivation, valuable suggestions, expert 
supervision, guidance and for making all necessary arrangements for 
conducting this study. 
I thank Prof. Dr. Jayaprakash, for his constant motivation and support 
apart from providing immense help and valuable suggestions in carrying out 
this study. His continuous support and ideas are the key factors for the 
construction of the study. 
I thank Prof. Dr. Bala Krishnan, for his constant motivation, guidance 
and valuable suggestions in carrying out this study. 
I thank Prof. Dr. Paramasivan, for his constant support and 
encouragement throughout the study. 
I thank Dr. Mahilamani, Asso. Prof. Department of Anesthesiology, 
SMIMS for her motivation, constant encouragement and support. 
I will be ever thankful to Late. Dr. Subramaniam for helping and guiding me 
in my work. He was a perfectionist, absorbed in work wanting his students 
excel in the field of anaesthesia. 
 I wish to thank Dr. Prasandan, Associate Professor, very knowledgeable 
teacher who is always eager to teach and share his knowledge. 
      I extend my gratefulness to Dr. Ravi Shankar, Assistant Professor, a 
good mentor and guide who tirelessly guided and encouraged me to strive and 
work hard. 
 I express my heartfelt gratitude to Assistant Professors Dr. Rommy, 
Dr. Beula, and Dr. Saji, who had evinced constant and keen interest in the 
progress of my study right from the inception till the very end and was 
instrumental in the successful completion of the study. 
 I thank Dr. Anitha R, my co-pg, for her valuable and timely help to 
complete my study on time. I also thank my colleagues Dr.Sheen, Dr.Shrey, 
Dr.Ashwini, Dr.Karikalan for helping me in various technical aspects of my study. 
I owe my gratitude to all the patients included in the study and their 
relatives, for their whole hearted co operation and consent. 
 
 
 
 
 
 
 
LIST OF CONTENTS 
Sl. No. Contents Page No 
1. Introduction  1-3 
2. Aims and Objectives 4 
3. Hypothesis and Scientific Justification 5-6 
4. Review of Literature 7-47 
5. Materials and Methods 48-56 
6. Results 57-74 
7. Discussion  75-80 
8. Conclusion 81 
9 Bibliography  i-vi 
10 Appendices  
 
 
 
 
 
 
LIST OF TABLES 
 
Sl. No Tables Page No 
1 Gender Distribution 58 
2 ASA Physical Status Distribution 59 
3 Weight Distribution 60 
4 Height Distribution 61 
5 Age Distribution                                   62 
6 Distribution of Surgery 63 
7 Duration of Surgery 64 
8 Efficacy of the drug 65 
9 Peak level of sensory blockade 66 
10 Time to complete Motor Blockade (Motor Grade 3) 67 
11 Duration of Blockade-Time to Rescue Analgesia 68 
12 Time to 2 Dermatome Regression 69 
13 Sedation Score at 10 Minutes 70 
14 Sedation Score at the end of surgery 71 
15 Changes in heart rate over time 72 
 
 
 
LIST OF FIGURES 
 
Sl. No Figures Page No 
1 Parts of Vertebral Bone 29 
2 Boundaries of Epidural Space 33 
3 Midline Approach for Epidural Space 39 
4 Tecnicniques to find out Epidural Space 43 
5 Paramedian Approach for Epidural Space 45 
6 Gender Distribution 58 
7 ASA Physical Status Distribution 59 
8 Weight Distribution 60 
9 Height Distribution 61 
10 Age Distribution 62 
11 Distribution of Surgery 63 
12 Duration of Surgery 64 
13 Efficacy of the drug 65 
14 Peak level of sensory blockade 66 
15 Time To Complete Motor Blockade 67 
16 Duration of blockade - time to rescue analgesia 68 
17 Time to 2 dermatome regression 69 
18 Sedation score at 10 minutes 70 
19 Sedation Score at the end of surgery 71 
20 Changes in heart rate over time 73 
 
LIST OF ABBREVATIONS USED 
 
 
 
  – Alpha 
mcg –  Microgram 
kg –  Kilogram 
mg  –  Milligram 
ml –  Millimeter 
ASA  –  American Society of Anesthesiology  
min  –  Minutes 
L2-L3-L4 –  Lumbar 
C1  –  Cervical 
T1  –  Thoracic 
S1 – Sacral 
PCA pumps – Patient Controlled Analgesia Pump 
SpO2  –  Partial Pressure of Saturation 
ADRS –  Adverse Drug Reactions 
MAP  –  Mean Arterial Pressure 
RL  –  Ringer Lactate 
HR  –  Heart Rate 
COPD –  Chronic Obstructive Lung Disease 
IV  –  Intravenous 
 
ABSTRACT 
 
Background:  
 The quality and duration of analgesia is improved when a local 
anaesthetics is combined with an alpha 2 adrenergic agonists. Both Clonidine 
and Dexmedetomidine are alpha 2 adrenergic agonists which have analgesic 
properties have been extensively studied and it has been established that 
Clonidine as an adjuvant, effectively prolongs the duration of action of local 
anaesthetics when given epidurally. There are limited studies demonstrating 
the effects of epidural Dexmedetomidine and its effects of local anaesthetics. 
Aims and objectives: 
 The aim of this study was to compare the effect of Clonidine and 
Dexmedetomidine in terms of anaesthesia, analgesia, sedation and side effects 
when used as an adjuvant to epidural Ropivacaine in lower abdominal and 
lower limb surgeries. 
Methodology: 
 Patients were randomized to two groups RC and RD by computer 
generated numbers. Group RC received 15 ml of 0.75% of Ropivacaine with 
1mcg/kg Clonidine and group RD 15ml of 0.75% of Ropivacaine with 1 
mcg/kg Dexmedetomidine epidurally. Onset of sensory analgesia –using pin 
prick, onset of motor blockade –using Bromage score, time to 2 dermatome 
regression of sensory level , time to first demand for analgesia, sedation – 
using Ramsay sedation scale, intra operative hemodynamic parameters and 
complications if any- nausea, vomiting, bradycardia, hypotension were noted. 
Results: 
 Both groups were comparable demographically with respect to age and 
sex distribution, height and weight characteristics. The onset and duration of 
sensory blockade was found to be significantly shorter in the RD group 
(p<0.005). The sedation in group RD was found to be significantly better than 
group RC (p<0.005). There was no significant difference found between the 
two groups in terms of onset of motor blockade and hemodynamic changes. 
Both groups had a similar incidence of hypotension and bradycardia which 
was not found to be significant. The side effects in both groups were minimal 
and comparable between the two groups. 
Conclusion: 
 We conclude that the addition of 1mcg/kg Dexmedetomidine as an 
adjuvant to 0.75% Ropivacaine in epidural anesthesia causes an early onset 
and prolonged duration of sensory analgesia in comparison to 1mcg/kg 
Clonidine. Epidural Dexmedetomidine cause better sedation as compared to 
Clonidine.  
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INTRODUCTION 
        Epidural anaesthesia is a versatile technique used for providing both 
anaesthesia and analgesia in the post operative period. It may be combined 
with regional anaesthesia or other forms of general anaesthesia. It can provide 
intra operative hemodynamic stability and has been proven to reduce 
perioperative stress response thus causing a decrease in the complications and 
help in improving patient outcome. It also helps in early mobilization of the 
patient by providing relief to post operative pain and decreases the incidence 
of  thromboembolic events.(1-5) 
 Epidural anaesthesia using Bupivacaine has been researched about in 
detail in the past. In the recent years Ropivacaine is being used increasingly 
due to similar analgesic properties but with lesser motor blockade and cardio 
toxicity.  A slightly larger dose of Ropivacaine is required when compared to 
Bupivacaine but the addition of an adjuvant helps in reducing the total dose 
required for local anaesthesia and adjuvant also enhances the efficacy, thereby 
increasing the duration of action and the intensity of blockade.(6-8) 
 
  
 A number of agents such as
be used as adjuvants to local anaesthetics that act synergistically thereby 
increasing the efficacy of the l
required dose and toxic side ef
 The duration and
anaesthetic is combined with an alpha 2 adrenergic agonist as adjuvant.
Dexmedetomidine and 
local anaesthetic effects
 Clonidine is an alpha 2 adrenergic agonist that enhances the action of 
local anaesthetic drugs on 
It acts by blocking 
thereby decreasing the intensity and duration of analgesia. It is known to 
cause sedation and the side effects of its use are 
hypotension.(13-16) 
 
 
 opioids, ketamine, and alpha agonists can 
ocal anaesthetic drugs, decreasing the total 
fects of both groups of drugs.(9,10
 the quality of analgesia can be improved when a local 
Clonidine are alpha 2 adrenergic agonists potentiates 
 and have analgesic properties.(10-12) 
 
administration via the epidural or intrathecal route. 
the A and C fibres and it causes local vasoconstriction 
b
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           Dexmedetomidine is a newer alpha 2 adrenergic agonist and is about 8 
times more selective α2 adrenoreceptor agonist than Clonidine and hence 
allows the use of higher drug dosage with less alpha1 effect. It has been found 
to have hemodynamic stability, anxiolytic, analgesic, sedative, neuroprotective 
and anaesthetic sparing effect. It causes intense motor blockade and co-
operative sedation without increasing the incidence of the adverse effects.(7-19) 
 Clonidine and Dexmedetomidine act on both pre and post synaptic 
sympathetic nerve terminals and also has central action which causes a 
decrease in the sympathetic outflow, leading to its analgesic, sedative, and 
hemodynamic effects.(13,15,16,18) The effects of Clonidine as an adjuvant with 
local anaesthetics has been studied extensively and it effectively prolongs the 
duration of action of the local anaesthetics when given epidurally. 
 The aim of our study was to compare the effect of Clonidine versus 
Dexmedetomidine when given as an adjuvant to Ropivacaine in epidural 
anaesthesia for lower abdominal and lower limb surgeries. 
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AIMS AND OBJECTIVES 
      To study and compare the effect of Dexmedetomidine and Clonidine in 
epidural anaesthesia when given as an adjuvant to 0.75% Ropivacaine 
1. The onset and duration of sensory blockade. 
2. The onset of motor blockade. 
3. The change in intra operative hemodynamic parameters. 
4. The level of sedation. 
5. Adverse effects (if any)  
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HYPOTHESIS AND SCIENTIFIC JUSTIFICATION 
Hypothesis 
 Epidural Dexmedetomidine prolongs the duration of anaesthesia with 
hemodynamic stability and improve post-operative analgesia. 
Scientific Justification 
 Neuraxial block for lower abdominal surgeries are becoming popular 
as its advantages are many as compared to general anaesthesia.  Epidural 
anaesthesia consists of the interruption of nerve transmission temporarily in 
the epidural space, an effect produced by the injection of a local anaesthetic 
(Ropivacaine 15ml) solution in the epidural space. The role of an 
anesthesiologist is to render pain free surgical procedures. 
 Anxiety is a common presentation in patients in the perioperative 
period, that starts few days prior to surgery and reaches its peak just before 
the induction of anaesthesia. Anxiety is also an intra-operative problem 
especially in patients undergoing surgical procedures under regional 
anaesthesia which leads to various manifestations like increasing oxygen 
demand, respiratory rate and heart rate due to the circulating level of 
endogenous catecholamines and their effects. Control of the anxiety and pain 
relief is necessary in an attempt to control the above mentioned metabolic 
derangements and for the comfort and safety of the patient in the 
perioperative period. 
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 Dexmedetomidine is a highly selective, potent α₂ - adrenoreceptor 
agonist that acts centrally with a short duration of action. It has the capability 
to sedate, hypnotize and provide analgesia that prolongs the duration of 
sensory and motor blockage obtained with epidural anaesthesia while still 
maintaining patient arousability and respiratory function. It is used epidurally 
with Ropivacaine. 
 In this dissertation we are studying the effects of Dexmedetomidine 
and Clonidine as an adjuvant to 0.75% Ropivacaine in epidural anaesthesia 
for lower abdominal or lower limb surgeries. 
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REVIEW OF LITERATURE 
Role of epidural anaesthesia: 
 Moraca et al(5) reviewed a number of meta analysis, retrospective and 
prospective studies to assess the benefits and complications of epidural  
anaesthesia and analgesia. They concluded that benefits of epidural anaesthesia 
includes suppression of surgical stress by sympatholysis, stable hemodynamics, 
reduction in postoperative pulmonary complications and effective pain relief, 
thus improving patient cooperation for physiotherapy and early mobilization 
leading to permitting earlier extubation, and reducing the length of stay. They 
also found 30% reduction of cardiac morbidity, 40% reductions in pulmonary 
complications and 30% reduction in blood loss. This review indicated 
significant reduction in perioperative complications and postoperative 
morbidity were associated with the use of epidural anaesthesia and 
postoperative analgesia. They also found that adding opioids to local 
anaesthetics provided better analgesia with less toxicity than either of the drugs 
alone. 
       Young et al(2) conducted study on 1,021 patients who required anesthesia 
for intra abdominal surgeries. The patients were divided into two groups, one 
receiving intravenous analgesics and other epidural.  The patients were 
monitored for perioperative complications and for 30 days after surgery. Post 
operative pain, time of ambulation and length of hospital stay was also noted. 
Review of Literature 
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Significantly fewer complications were seen with epidural anesthesia and 
hence concluded that epidural anesthesia and analgesia eliminate the 
perioperative physiological stress responses. This lead to decrease in surgical 
complications by providing better analgesia, decreased ICU stay and 
improving outcomes. 
 John Riggs et al(4) studied 915 high risk patients undergoing major 
abdominal surgery in their MASTER anaesthesia Trial Study. They found no 
significant advantage in combining epidural with general anaesthesia. 
However there was improvement in analgesia, reduction in respiratory 
complications and the lower risk of adverse consequences that suggests high-
risk patients undergoing major intra abdominal surgery may substantially 
benefit from effect of combined general and epidural anaesthesia intra 
operatively and continued postoperative epidural analgesia. 
Ropivacaine in epidural anaesthesia: 
 Sara et al(20) conducted a study in sixty-one patients who were  
randomly  assigned to two groups receiving either 15ml of 0.75% 
Ropivacaine or 0.5% Bupivacaine epidurally.  They looked into the motor and 
sensory block intensity which was superior with Bupivacaine in the first 
30minutes. Later there was no significant difference between the two groups. 
The duration of sensory and motor block was similar in the two groups and no 
statistical significant side effects were noted in both group. They concluded 
that 0.75% Ropivacaine was equipotent to 0.5% Bupivacaine. 
Review of Literature 
 
9 | P a g e  
 
 Shalina(6) et al compared 0.75% Ropivacaine and 0.5% Bupivacaine in 
epidural anaesthesia in patients undergoing lower limb orthopaedic surgeries.  
The patients were randomized into groups to receive Ropivacaine 0.75% and 
Bupivacaine 0.5%. Epidural block was performed using an 18G Touhys 
needle and test dose of 2% Lignocaine with 1:200000 Adrenaline was given 
as test dose after which 20ml of the test solution was injected into the epidural 
space. The onset of sensory and motor block time to two dermatome 
regression, duration of analgesia and time to complete motor blockade and 
side effects were studied. They found that the block parameters were 
comparable and showed no significant difference. 
Clonidine as an adjuvant to local anaesthetics: 
Eisenach et al(13) studied the effects of epidural Clonidine in terms of 
hemodynamic changes and analgesia. All nine patients received a dose of 
700mcg of Clonidine in 7ml of isotonic saline which was injected into the 
epidural catheter over five minutes. The CSF, arterial and venous blood 
samples were collected to assess the pharmacokinetics along with continuous 
monitoring of the heart rate and blood pressure. It was found that Clonidine 
was absorbed rapidly into the systemic circulation after epidural injection 
with a peak at 11.8±1.9 minutes and it reached peak CSF concentration in 
about 30 minutes. They inferred that hemodynamic effects correlated to the 
onset and peak concentrations of Clonidine in the CSF; hence the changes in 
the heart rate and the blood pressure begin 30 minutes of administration and 
Review of Literature 
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peak within 1 to 2 hours and last for 6 to 8 hours. The direct action of 
Clonidine on the spinal cord causes inhibition of the pre ganglionic nerve 
fibres causing decrease in the sympathetic outflow resulting in hypotension. 
Clonidine causes bradycardia by increasing vagal activity and baroreceptor 
reflexes and also by direct action on the heart. These side effects are dose 
dependent and are observed at doses above 150 mcg. Sedation after epidural 
administration is due to systemic absorption and redistribution to the higher 
centers. Clonidine causes inhibition of the locus coeruleus which is the center 
of regulation of sleep and wakefulness. It is known to cause dose dependent 
sedation with an onset of around 20 minutes.    
A study was conducted by Bapista et al(21) in 80 patients undergoing 
hemorrhoidectomy under epidural anaesthesia to assess the safety, pain 
intensity correlated  with age and body mass  index, epidural anaesthesia with 
Ropivacaine and Clonidine, one group received 14ml of Ropivacaine 0.75% 
alone  and the other 14ml of Ropivacaine 0.75% with  Clonidine 4mcg/kg. 
VAS score (p=0.0000) was significantly lower in the Clonidine group. They 
concluded that Ropivacaine 0.75% along with Clonidine(4mcg/kg) provided 
better analagesia with fewer hemodynamic changes. 
Bajwa et al(22) studied epidural Ropivacaine and Ropivacaine with 
Clonidine for elective caesarean sections. Patients were randomly divided into 
two groups with epidural anaesthesia 20ml 0.75% Ropivacaine (group R) and 
20ml 0.75% Ropivacaine with 75mcg Clonidine (group RC). Anaesthetic level 
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achieved was a minimum of T6-T7 dermatome.  The onset of analgesia was 
much shorter in RC group (8.64±2.56 minutes) along with prolonged duration 
of analgesia (173.50±32.44). Analysis of results revealed that the incidence of 
bradycardia and hypotension was significantly higher in the Clonidine group 
(p>0.05). The dose requirement for postoperative pain relief was significantly 
lesser in the RC group. The authors concluded that addition of 75mcg of 
Clonidine to isobaric Ropivacaine resulted in longer and more effective 
analgesia. 
Alves et al(23) conducted a double blinded study in 70 patients who 
were undergoing lower abdominal, perineum or lower limb surgeries. The 
study candidates were divided into 2 groups. In the one group, 0.75% 
Ropivacaine(150mg) was used and in other, Clonidine(300mcg) and 0.75% 
Ropivacaine (150mg) was given as epidural anaesthesia. Onset of sensory 
block at T10 was 18±9 and 17±07 minutes in the control group respectively. 
But, an increase in the duration of motor and sensory block along with more 
sedation in the Clonidine group was noticed which was statistically significant 
(p<0.001). Significant bradycardia was seen in the Clonidine group. There 
was also decreased incidence of tremors. 
Clonidine hydrochloride combined with a diuretic agent was given to 
57 patients for a period of 6 months to 2 years. It was shown to be an effective 
agent for the long-term treatment of hypertension. It acts by central inhibition 
of adrenergic vasomotor stimulation; its withdrawal can cause transient 
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sympathoadrenal hyperactivity. Dry mouth, constipation and transitory 
drowsiness were the most common side effects. They diminished with time, 
even when the dose was progressively increased. Bradycardia was produced 
by inhibition of cardiac sympathetic innervation, but no serious dysrhythmias 
occurred. 
The drug can be used to advantage as a replacement for Guanethidine 
or Methyldopa but must be given with a diuretic agent. Orthostatic 
hypotension was rare. Addition of hydralazine or reserpine in conventional 
dosage decreased blood pressure very moderately. No change was observed 
when alpha Methyldopa was added. On the contrary, administration of 
Clonidine to a patient exhibiting partial adrenergic blockade with 
Guanethidine augmented the effects of such blockade, causing a further 
decline in both standing and recumbent blood pressure. 
This 3 year of study shows that Clonidine is safe and free from 
toxicity. It is effective if patiently administered in increasing dosage until 
proper control of blood pressure is achieved. To evaluate the characteristics of 
patients receiving Clonidine and its effect on Blood Pressure (BP).Design and 
method: Retrospective study of patients with chronic kidney disease (CKD) 
evaluated in Clinic Consultation of Nephrology / Nephrology Hypertension, 
with uncontrolled hypertension who were treated with Clonidine. In patients 
with chronic kidney disease hypertension is prevalent and often is very 
difficult to control, not only due to the severity of the disease itself but also 
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due to the necessary personalization of prescribed drugs. Central acting alpha 
agonists are useful as "adjuvant" therapeutic drugs increasing the proportion 
of patients with controlled disease. 
Nakayama M, et al. in 2001 studied analgesic effect of epidural 
Neostigmine after abdominal hysterectomy. They administered epidural 
Bupivacaine (10mg) with either saline (control group), 5mcg/kg(5mcg group) 
or 10 mcg/kg Neostigmine (10mcg group). They concluded that epidural 
Neostigmine of 10mcg/kg in Bupivacaine provides longer duration of 
analgesia than does Bupivacaine alone with 5mcg/kg of Neostigmine after 
Neostigmine. 
Shoji K, Saito H and Masaki E in 2004 conducted a study to determine 
whether pre incisional epidural Neostigmine co administered with 
Ropivacaine modulates stress response and postoperative pain status. In 20 
patients for abdominal hysterectomy either 10ml of 0.75% Ropivacaine alone 
or along with 300mcg Neostigmine was administered before induction of 
general anesthesia. They concluded that epidural Neostigmine coadministered 
with Ropivacaine does not change stress responses and fails to improve the 
postoperative analgesic effects of the local anesthetic. 
Asida SM, Magid MA, Korany A in 2007 conducted a study on sixty 
patients 1-5years of age admitted for lower abdominal and lower extremity 
operations and divided into two groups receiving 0.5ml/kg of 0.2% 
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Ropivacaine and 0.5ml/kg of 0.2% Ropivacaine plus 2mcg/kg Neostigmine to 
Ropivacaine given by the caudal route to children improves the quality of 
anaesthesia and postoperative analgesia more than Ropivacaine alone. 
Dexmedetomidine as an adjuvant to local anaesthetics: 
 Paula et al(24) studied the effects of epidural Ropivacaine with 
Dexmedetomidine in 40 patients undergoing inguinal hernia or varicose vein 
surgical repair. The patients were divided into 2 groups, the first received 
20ml of 0.75% Ropivacaine with 1mcg Dexmedetomidine in the epidural 
space. The monitored parameters were onset of sensory blockade, time to 
block dermatomes T12,T10 and T8, maximum dermatome level reached, 
degree of motor blockade, motor blockade duration, duration of analgesia, 
need for additional analgesia and sedation. Any occurrence of hypotension 
and bradycardia and other side effects were also assessed. There was no 
statistical difference between the two groups in relation to age, weight, height 
and sex. They found no statistical difference between the two groups in the 
time taken to block dermatomes T12, T10 and T8. The maximum level of 
sensory analgesia achieved in both groups was at T6. In the group receiving 
Dexmedetomidine the duration of sensory blockade, the duration and intensity 
of motor blockade was found to be significantly higher. It was found that 70% 
of patients from the group who were given only Ropivacaine injection, 
required additional sedation. This was in contrast to 26% of patients who 
received adjuvant Dexmedetomidine. Based on their observations, they 
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concluded that Dexmedetomidine acts synergistically with 0.75% 
Ropivacaine as an effective and a safe epidural anesthetic and analgesic. 
 Yu-Nan Lin et al(25) studied the effects of adding Dexmedetomidine to 
Ropivacaine for cervical plexus block. Forty patients who underwent thyroid 
surgery were divided into two groups randomly. Patients in Dexmedetomidine 
group received 30ml of 0.375% Ropivacaine with 1mcg/mg of 
Dexmedetomidine while, those in the control group received 30ml of 0.375% 
Ropivacaine with saline. Onset of sensory blockade was 4.72 minutes in 
group D and was 6.64 minutes in group C, which was statistically significant. 
There was also a significant increase in the duration of blockade in group D in 
comparison to group C. The degree of sedation was also higher in the group D 
patients. The mean arterial pressure and heart rate in group D was found to be 
significantly lower than in group C in the dexmedetominidine, two patients 
were found to have bradycardia and were treated with atropine. Based on 
these findings, they inferred that the addition Dexmedetomidine to 
Ropivcaine for cervical plexus block could shorten the onset and extend the 
duration of analgesia, while providing adequate sedation. 
 Oriol-Lopez et al(26) conducted a study in 40 patients between the ages 
of 18 to 65 years who underwent lower abdominal or lower limb surgery 
under epidural anesthesia. 2% Lignocaine with adrenaline was given along 
with 1mcg/kg Dexmedetomidine was administrated through the epidural 
needle. The patient was then assessed for sedation using Ramsays sedation 
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scale and hemodynamic changes, degree of analgesia were assessed and 
recorded at 5, 10, 15 and 30 minutes, subsequently every half hour until the 
end of the anesthetic and surgical events. 17% of the patients had a sedation 
score of 3 within 5 minutes and 90% of the patients had a sedation level of 3-
4 from 15 to 90 minutes, 4 patients had a sedation score of 5 from 30-60 
minutes. They concluded that adequate sedation was maintained between 10 
to 120 minutes with a single epidural bolus dose of Dexmedetomidine and 
may be considered as an alternative to achieve active sedation with reduced 
respiratory depression which may arise on using large dose of intravenous 
sedatives.  
 In a randomized controlled study of 60 patients undergoing lower limb 
surgeries done by Jain D et al assessing the effects of epidural 
Dexmedetomidine in patients receiving intrathecal Bupivacaine, it was noted 
that  Dexmedetomidine significantly increased the duration to 424 minutes in 
contrast to 140 minutes in the placebo group. Both groups received 2.5ml of 
0.25% Bupivacaine intrathecally and the control group received 10ml of 
saline in the epidural while the Dexmedetomidine group received 2mcg/kg 
Dexmedetomidine made to a volume of10ml. In the Dexmedetomidine group, 
they observed significantly (p=0.000) decreased requirement of rescue 
analgesia and better sedation within 10 minutes of the injection and which 
lasted  for 45-50 minutes. They observed a fall in mean arterial pressure and 
heart rate 5 minutes following the injection which lasted till the end of 
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surgery. Hence they concluded that addition of Dexmedetomidine epidurally 
not only prolongs the duration of analgesia and provide adequate sedation but 
also decreases the requirement of rescue analgesics with associated 
hypotension and bradycardia. 
 Bajwa et al(11) compared Dexmedetomidine and Clonidine as adjuvants 
to Ropivacaine in epidural anesthesia in patients undergoing vaginal 
hysterectomy. One group received 17ml of Ropivacaine 0.75% with 
dexmeditomidine 1.5mcg/kg and the other 17ml of Ropivacaine 0.75% with 
2mcg/kg Clonidine and the block characteristics were observed. There was an 
early onset of sensory block in the patients receiving Dexmedetomidine as 
compared to Clonidine which was not statistically significant. The sedation 
was significantly better (p<0.05) in the Dexmedetomidine group when 
compared to Clonidine group. The mean time for two sensory dermatome 
regression and motor regression was prolonged in the Dexmedetomidine 
group. The time for first rescue analgesia was also significantly prolonged in 
the Dexmedetomidine group. The side effect between two groups was similar 
with an increased incidence of nausea and dry mouth. When compared to 
Clonidine, Dexmedetomidine was a better adjuvant to Ropivacaine. 
 A similar study was conducted by Swami et al(12) in patients  
undergoing upper limb surgeries, comparing 1mcg/kg Dexmedetomidine and 
Clonidine as adjuvants in supraclavicular brachial plexus block. Both groups 
were found to be comparable in terms of demographic profile, type and 
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duration of surgery. There was a significantly longer duration of motor and 
sensory blockade in the group of patients receiving Dexmedetomidine as 
compared to the group receiving Clonidine. It was also found that, there was a 
significant increase in the duration of analgesia in the Dexmedetomidine 
group in comparison to the Clonidine group. The quality and intensity of 
block was higher in Dexmedetomidine group than in the Clonidine group. 
Hence they concluded that Dexmedetomidine increased both the quality and 
the duration of brachial plexus block in comparison with Clonidine when used 
as an adjuvant to Ropivacine. 
 A comparative study of caudal Dexmedetomidine at 1mcg/kg and 
Clonidine at 1mcg/kg as adjuvant to 0.25%Bupivacaine in children undergoing 
below umbilicus surgeries done by Raval et al showed significantly better 
block characteristics in children receiving Dexmedetomidine Children were 
administered caudal anaesthesia with 1ml/kg of 0.25% Bupivacaine with 
1mcg/kg of the study drug (Clonidine or Dexmedetomidine) was given. An 
increase in pulse rate and blood pressure of more than 20% to surgical incision 
was considered failure of caudal blockade. Post operatively patients were 
monitored for changes in heart rate, blood pressure and saturation and analgesia 
was assessed using the CRIES scale. The duration of analgesia in children 
receiving Dexmeditomidine was 14±1.6 hours in comparision to Clonidine 
which was 11±2.4 hours. There was however, no significant difference in the 
hemodynamic changes between the 2 groups.  
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 El-Hennawy28 et al compared the effects of Clonidine and 
Dexmedetomidine as adjuvants to Bupivacaine in caudal anaesthesia. Caudal 
anaesthesia was induced with 0.25%Bupivacaine at 1ml/kg with 2mcg/kg of 
either Dexmedetomidine or Clonidine. They found no significant difference 
between the two groups in terms of duration of analgesia hemodynamic 
profile and side effects (p=0.796).They observed that there was no significant 
difference between Dexmedetomidine and Clonidine as adjuvants to local 
anaesthesia. 
 In a recent meta analysis, Abdulla & Brull(29), who reviewed nine 
randomized control studies to determine if, Dexmedetomidine when used as 
an adjuvant to local anesthesia alone, causes prolongation of analgesia. They 
inferred that unlike Clonidine, which increases the duration of only short 
acting local anaesthetics, Dexmedetomidine clearly prolonged the duration of 
block of long acting local anaesthetics. They also suggested that 
Dexmedetomidine may not produce preferential sensory block like Clonidine, 
which may be a disadvantage as it can delay rehabilitation. There was no 
obvious association between Dexmedetomidine and the incidence of 
hypotension or respiratory depression, however felt that most studies are were 
not aimed at determining the safety of demedetomidine and long terms studies 
required to efficiently assess the safety of Dexmedetomidine as no study was 
able to justify the compatibility or safety of the combination of local 
anaesthetics with Dexmedetomidine. Hence they concluded that there is 
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currently insufficient data in the clinical setting to support the advantage and 
safety of perineural and neuraxial Dexmedetomidine with local anaesthetics. 
 Ropivacaine is a long-acting local anaesthetic, with a low lipid 
solubility and a high pKa which blocks nerve fibres involved in pain 
transmission (A delta and C fibres) to a greater degree than those controlling 
motor function (beta fibres). The drug was less cardiotoxic than equal 
concentrations of racemic Bupivacaine but more so than Lidocaine 
(Lignocaine) and its threshold for CNS toxicity is significantly higher than 
racemic Bupivacaine in healthy volunteers (mean maximum tolerated 
unbound arterial plasma concentrations). Extensive clinical data have shown 
that epidural Ropivacaine 0.2% is effective for the initiation and maintenance 
of labour analgesia, and provides pain relief after abdominal or orthopaedic 
surgery especially when given in conjunction with opioids (coadministration 
with opioids may also allow for lower concentrations of Ropivacaine to be 
used). The drug had efficacy generally similar to that of the same dose of 
Bupivacaine with regard to pain relief but caused less motor blockade at low 
concentrations. Lumbar epidural administration of 20 to 30ml Ropivacaine 
0.5% provided anaesthesia of a similar quality to that achieved with 
Bupivacaine 0.5% in women undergoing caesarean section, but the duration 
of motor blockade was shorter with Ropivacaine. For lumbar epidural 
anaesthesia for lower limb or genitourinary surgery, comparative data suggest 
that higher concentrations of Ropivacaine (0.75 or 1.0%) may be needed to 
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provide the same sensory and motor blockade as Bupivacaine 0.5 and 0.75%. 
In patients about to undergo upper limb surgery, 30 to 40ml Ropivacaine 
0.5% produced brachial plexus anaesthesia broadly similar to that achieved 
with equivalent volumes of Bupivacaine 0.5%, although the time to onset of 
sensory block tended to be faster and the duration of motor block shorter with 
Ropivacaine. Ropivacaine had an adverse event profile similar to that of 
Bupivacaine in clinical trials. Several cases of CNS toxicity have been 
reported after inadvertent intravascular administration of Ropivacaine, but 
only 1 case of cardiovascular toxicity has been reported to date. The outcome 
of these inadvertent intravascular administrations was favourable. 
Ropivacaine is a well tolerated regional anaesthetic with an efficacy broadly 
similar to that of Bupivacaine. However, it may be a preferred option because 
of its reduced CNS and cardiotoxic potential and its lower propensity for 
motor block.(38) 
 Ropivacaine is a new amide local anaesthetic, which is the first 
commercially available in its category as a pure S-(-) enantiomer. In most 
recent studies, Ropivacaine exhibited a very close pharmacodynamic profile 
to equipotent doses of Bupivacaine. Concentrations of 0.5%, 0.75% and 1% 
(5, 7.5 and 10 mg/mL, respectively) Ropivacaine are used for intraoperative 
anaesthesia, while the concentration of 0.2% is preferred for postoperative 
analgesia, either alone or in combination with opioids and/or Clonidine. 
Ropivacaine is responsible for excellent postoperative analgesia following 
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epidural and peripheral perineural injections, using single-shot injections 
and continuous infusions. Differential sensory/motor block is only apparent 
at low concentrations (0.2% and less). A significant amount of recent 
literature focuses on its use for peripheral blocks of the lower limbs, i.e, 
sciatic and femoral nerve blocks. The primary benefit of Ropivacaine is its 
lower toxicity, mainly lower cardiotoxicity, following accidental 
intravascular injection. This higher therapeutic index leads to an improved 
safety profile as compared with potent local anaesthetics such as racemic 
Bupivacaine. For that reason, Ropivacaine is a good choice for both 
intraoperative and postoperative regional anaesthesia and analgesia.(39) 
 Caudal ropivacine has been shown to cause less motor blockade and 
longer duration of analgesia in the postoperative period than Bupivacaine in 
children. This study was undertaken to compare the total venous plasma 
concentrations of similar doses of Ropivacaine and Bupivacaine following 
caudal administration. 
 The plasma concentrations of Bupivacaine were significantly lower 
than for Ropivacaine at 60, 90 and 120 min after the block Absorption and 
tissue distribution of Ropivacaine is slower than for Bupivacaine following 
caudal administration in children.(40) 
 The study was designed to evaluate the clinical efficacy and motor 
blockade properties of the drug when used in lower volumes and higher 
concentrations of plain substances. In a randomised, double-blind study plain 
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Ropivacaine (ro) 1% (150 mg) and Bupivacaine (bu) 0.75% were compared in 
44 patients. In the lateral position, epidural anaesthesia was performed at L2/3 
or L3/4 using the loss-of-resistance technique. A test dose of 3 ml was given 
followed by 12 ml (total volume 15 ml). Sensory blockade was registered by 
the pin-prick method after 2 min at 5 min intervals up to maximal levels and 
after the operation at 30-min intervals. Simultaneously, the motor block was 
determined by means of the Bromage scale. Results are given as median 
values.  The onset of analgesia was 6.0 min for both substances (L2), the time 
to level L5 16.0 and 17.0 min respectively. The median maximum upper level 
of sensory analgesia was achieved after 24.5 min with ro (Th 5) and after 21.0 
min (Th 7) with bu. The maximum durations (regression to L2) were 321.5 
(ro) and 266.0 min (bu) (P < 0.05). Times for 2-segment regression were 
comparable at 177.5 and 176.0 min, respectively, and for 4-segment 
regression at 201.3 and 222.0 min. Twenty-one of the 22 patients developed a 
first-degree motor block; 16 patients in the (ro) group developed a second-
degree block, as did 14 in the (bu) group. Third-degree motor block was 
recorded in 3 patients. The duration of first-degree motor block was 233 min 
and 207 min, of second-degree block 150 and 155 min, and third-degree block 
135 min in both groups. The mean arterial pressures and heart rates did not 
differ. The diastolic pressures were lower after (bu) than after (ro) at 30 min. 
No major side effects were observed. Theodrenaline and/or dihydroergotamine 
(1:10 diluted) was administered to 38.6% of the patients; 34.1% received 
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atropine for the treatment of bradycardias and hypotension of more than 20%. 
No significant differences were found in frequency of analgesia (pin-prick) 
between both groups. One of 22 patients in the ro group and 6 of 22 in the bu 
group required additional analgesics or general anaesthesia. With 2 patients 
after ro and 4 patients after bu the relaxation was insufficient for good 
operating conditions. Ropivacaine 1% produced a longer duration of analgesia 
and better clinical efficacy than Bupivacaine 0.75%. The clinical difference in 
motor blockade was not statistically significant. The Bromage scale is not 
representative for a substance with good analgesic effects and moderate motor 
blocking properties as has been shown in sophisticated studies on Ropivacaine 
motor blockade.(41) 
 Bupivacaine and Ropivacaine both have been shown to be effective 
equally in providing sensory block for lower extremity surgery through 
epidural route, but they both have never been compared for the ability to 
produce abdominal wall relaxation. A randomized study done on 18-70 years 
old undergoing elective gynecologic surgery, in an institutionally approved 
protocol. Some received a single injection of 20 ml 0.75% of Bupivacaine at 
the interspace (L2-L3-L4) and some received 20 ml 0.75% of Ropivacaine in a 
similar manner. Sensory block was tested using pinprick; motor block was 
tested with a modified Bromage scale, and rectus abdominis muscle (RAM) 
test and also surgeon’s satisfaction. Time to achieve peak sensory block and 
peak sensory level were similar in both the groups. However, the time to 
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complete sensory regression was longer with Bupivacaine than with 
Ropivacaine. Bupivacaine’s motor block onset in the lower extremity was 
significantly faster than Ropivacaine. Time to peak lower extremity motor 
block was shorter with Bupivacaine than with Ropivacaine. Duration of lower 
extremity motor blockade was longer with Bupivacaine than Ropivacaine. 
There were no significant difference between the two groups of drug for 
changes in RAM scores. Peak motor block scores using the modified Bromage 
score and surgeon’s satisfaction with the operating conditions also did not have 
a significant difference between the two groups.(42) Both (0.75% Ropivacaine 
and 0.75% Bupivacaine) provide adequate surgical anaesthesia for lower 
abdominal surgery when administered via epidural route. However, lower 
extremity motor blockade with Ropivacaine is significantly shorter with slower 
onset and sensory blockade shorter at these concentrations than Bupivacaine.(43) 
 Kampe et al., (1999) assessed the analgesic efficacy of Ropivacaine 0.1% 
with or without Sufentanyl 1µg/ml in a prospective randomized double blind study 
involving 30 ASA I-III patients undergoing elective hip replacement surgery with 
epidural infusion at 5-9 ml/hour. They found that motor blockade was negligible in 
both groups and addition of Sufentanyl 1microgrm/ml to Ropivacaine 0.1% 
decreased the opioid requirement by six folds.(18) 
 Berti et al., (2000) in a Prospective, randomized, double-blind study 
involving 32 patients evaluated the effects of addition of low dose Fentanyl (2 
microgram/ml) to either 0.2% Ropivacaine or 0.125% Bupivacaine on 
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postoperative analgesia through PCA pumps after major abdominal surgery. 
They used a basal epidural infusion of 4ml/hour with incremental dose of 1.5ml 
and 20 minutes lockout interval. They found no differences in pain relief, motor 
block, degree of sedation and recovery of gastrointestinal motility between the 
two groups. However they reported the request for incremental doses and more 
analgesic solution consumption in patients receiving Ropivacaine alone than 
patients receiving the Ropivacaine/ Fentanyl mixture and also a significant 
decrease in peripheral SpO2, lasting up to 48 hours after surgery in the latter 
group. They concluded that 0.2% Ropivacaine with or without Fentanyl 
provided adequate pain relief in most patients with a very low degree of motor 
blockade and adding 2 microgram/ml Fentanyl to 0.2% Ropivacaine reduced 
total consumption of local anesthetic and also need for incremental doses. But 
there was no 10 clinically relevant advantages in quality of pain relief and 
incidence of motor block with addition of Fentanyl.(17) 
 Pouzeratte et al (2001) compared analgesic efficacy, adverse effects of 
Ropivacaine with Bupivacaine, both combined with Sufentanyl and also the 
efficacy of Ropivacaine 0.2% alone in 60 patients who underwent abdominal 
surgery. It was a prospective, randomized, double-blinded study. The patients 
were randomly allocated into three groups to receive 0.25% Bupivacaine with 
1mcg/ml Sufentanyl 0.25% 
 Ropivacaine with 1mcg/ml Sufentanyl and 0.75% Ropivacaine alone 
intraoperatively. This was followed by 0.125% Bupivacaine with 0.5mcg/ml 
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Sufentanyl, 0.125%Ropivacaine 0.5mcg/ml Sufentanyl and 0.2% Ropivacaine 
alone for postoperative analgesia. They found that the local anaesthetic 
consumption was less among Bupivacaine with Sufentanyl group when 
compared with that of Ropivacaine with Sufentanyl and Ropivacaine alone (P 
= 0.0003 and P =0.0003, respectively). Addition of Sufentanyl to Ropivacaine 
optimized its analgesic efficacy as denoted by decreased consumption of local 
anaesthetics in Ropivacaine with Sufentanyl group. They concluded that 
addition of 0.5 mcg/ml Sufentanyl to 0.125% Ropivacaine provided more 
effective postoperative epidural analgesia than 0.2% Ropivacaine alone. In 
combination with Sufentanyl, Ropivacaine was less potent than Bupivacaine 
by a factor of 0.75% in reliving the pain(21) 
 Kida K, et al in 2008 conducted a study to determine whether 
intraoperative systemic Dexmedetomidine improves postoperative pain and 
interacts with epidural Neostigmine to produce analgesic effects. They 
concluded that the intraoperative systemic infusion of Dexmedetomidine 
alone at doses causing sedation does not result in postoperative analgesic 
effects. However, the co-administration of systemic Dexmedetomidine and 
epidural Neostigmine at higher doses may be a useful method to improve 
postoperative pain management. 
 In 2010, Tealab, et al. studied potentiation of epidural labour analgesia 
using concomitant Ropivacaine and fentanyl by two doses Neostigmine. They 
divided 60 parturients into 3 groups and administered 0.1% Ropivacaine with 
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100mcg fentanyl and 0.1% Ropivacaine with 100mcg fentayl with either 
500mcg or 750mcg. They noted long lasting and effective analgesia. They 
concluded that 500mcg Neostigmine is as effective epidurally as 750mcg. 
 Taspiner V, Pala Y, Diker S et al in 2012 studied pre emptive analgesia 
and hemodynamic efficacy of epidural Neostigmine. They concluded that pre 
emptive 8mcg/kg epidural Neostigmine reduced analgesic consumption with 
low frequency of adverse effects. 
ANATOMICAL ASPECTS OF VERTEBRAL COLUMN 
 Anatomy holds a central position in regional anesthesia because of 
obvious necessity of correctly delivering the therapeutic solutions to the target 
neural structures. 
Vertebral Bones 
 The vertebral column is a flexible and flexuous column, formed by 
series of bones called vertebrae. 
 The spine consists of 33 vertebrae.  
• 7 cervical (C1-7) 
• 12 thoracic (T1-12) 
• 5 lumbar (L1-5) 
• 5 sacral (S1-5 fused into one) 
• 4 coccygeal (often fused into one) 
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 The upper 3 regions remain distinct throughout life, and are known as 
true or movable vertebrae; those of the sacral and coccygeal are termed fixed 
or false vertebrae. Although the vertebrae differ in design at different levels of 
vertebral column, common elements can be defined. 
 The cervical, thoracic and lumbar vertebrae have certain differentiating 
features. Cervical vertebrae differ from the thoracic and lumbar vertebrae in 
having foramina in their transverse process. The thoracic vertebra differs from 
the lumbar and cervical vertebrae in that they have articular facets for ribs on 
their bodies. 
 Atypical lumbar vertebra is made up of the following parts: 
1. The body 
2. Vertebral arch 
3. Transverse processes 
4. Spinous process 
5. Superior and inferior articular processes. 
 
Fig 1. Parts of Vertebral Bone 
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Body:  
 It is kidney shaped. They are weight bearing. The flat articular surfaces 
are covered with hyaline cartilage, which is firmly united to the 
fibrocartilagenous intervertebral discs (annulus fibrosus and nucleus 
pulposus). The anterior and posterior longitudinal ligaments reinforce the 
union the between the bodies. The broad anterior longitudinal ligaments is 
firmly attached to the intervertebral discs and loosely attached to bodies. The 
posterior longitudinal ligament is narrower and is similarly attached. 
Vertebral arch: 
 It is composed of pedicles and laminae, that surround the spinal cord 
and its coverings and protect it. Each half of the vertebral arch is divided into 
two parts by the root of the transverse process. Anteriorly, the arch is formed 
by the powerful rounded pedicle whose function is to transmit stress. 
Posteriorly, it is completed by the lamina, which is flat and is mainly 
protective in function. From the vertebral arches 4 articular processes project, 
2 upward and 2 downward to articulate with similar processes of the adjacent 
vertebrae. 
Transverse processes: 
 They are two in number. They are thin and long. They act as levers 
for muscles and ligaments particularly concerned in rotation and lateral 
flexion. 
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Spinous process: 
 It is almost horizontal, quadrangular and thickened along its posterior 
and inferior borders. They act as levers for muscles which control posture and 
active movements of the vertebral column. 
 Spinous processes of the cevical, the first two thoracic, and the last 
four lumbar vertebrae are all particularly horizontal and are therefore opposite 
the bodies of their respective vertebrae. The other spinous processes are 
inclined in the downward direction, with their tips opposite the bodies of the 
vertebrae below. Exception is the tip of the first lumbar spinous process, 
which is opposite the intervertebral disc. 
Superior and inferior articular processes: 
 The superior articular processes spring from the junctions of pedicles 
and laminae. They project upwards behind the pedicles and come to lie just 
above the level of transverse processes and the articular facets on their 
posterior surfaces face backwards and medially. The inferior articular 
processes extend downwards from the infero lateral aspects of the laminae. 
They lie below the level of the transverse process and the articulate with the 
facets on the superior articular processes of the vertebra below. 
Intervertebral Foramina:  
 The lateral aspect of the vertebral column presents a series of intervertebral 
foramina through which the spinal nerves and accompanying vessels passes. It 
provides passage between the paravertebral space and the vertebral canal. 
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 The areolar tissue around these foramina is soft and loose in the young 
individual and the anesthetic solution and catheter may also pass through one 
of these foramina. For this reason lesser amount of local anesthetic solution is 
required to produce an epidural block in the elderly as compared to young 
individuals. 
 The sacral and coccygeal vertebrae fuse at puberty. Marellously exact 
system of ligaments, interposed cartilages and muscles at with synergestic and 
antagonistic precision to hold these vertebrae together and to keep the 
vertebra column from collapsing.  
 There are 4 anatomical curvatures in the vertebral column of which, 
the thoracic and the sacral are primary and concave anteriorly and the cervical 
and the lumbar are secondary and convex anteriorly. These curves have a 
significant influence on the spread of local anesthetic in the sub arachnoid and 
the epidural space. 
LIGAMENTS: 
 The vertebral column is bounded together by several ligaments, which 
gives it stability and elasticity 
1. The Supraspinous ligament 
2. The Interspinous ligament 
3. The Ligamentum flavum 
4. The Anterior longitudinal ligament and 
5. The Posterior longitudinal ligament 
  
Fig 2. 
Supraspinous Ligament
 It is a strong thick fibrous band connecting the apices of the spines 
from the 7th cervical vertebra o
broad. In cervical region, it blends into the neck ligaments, where it is 
specialized as the ligamentum nuchae and extends from 7
to occipital protuberance.
Interspinous Ligament
 It is a thin fibrous structure connecting adjacent spines. The fibres are 
almost membraneous and extends from the apex and upper surface of the 
lower spine towards the root and inferior surface of the next higher vertebrae. 
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They meet the supraspinous ligament posteriorly and tend to blend with 
ligamentum flavum in front. 
Ligamentum Flavum 
 It consists of yellow elastic tissues. The fibres are perpendicular in 
direction. They extend from the anterior inferior surface of upper lamina 
downward to the anterior superior surface of lower lamina. Ligament exsist as 
a right and left half. Internal surface of left and right ligamentum flavum form 
an acute angle with its vertex in contact with the interspinous ligament. The 
dorsomedian connective tissue band extends from the apex of the ligamentum 
flavum and the periostium through the extradural space to the spinal dura 
matter. 
Posterior Longitudinal Ligamnent 
 Runs within the vertebral canal and posterior surfaces of body of 
vertebrae from which it is separated by the basivertebral veins. 
Anterior Longitudinal Ligament 
 Runs along the front of vertebral bodies, it is adherent also to the 
intervertebral discs. 
Spinal Meninges 
 The spinal cord is ensheathed by three membranes from without in 
Dura mater: spinal dura mater; represents only the inner or meningeal layers 
of cerebral dura mater: the outer or endosteal layers, being represented by the 
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extradural space. It is connected by fibrous slips to posterior longitudinal 
ligament, especially near lower end of vertebral canal. A strong fibrous layer 
forms a tubular sheath attached above to margins of foremen of magnum and 
ending below at lower border of second sacral vertebra. 
 Arachnoid mater: this is a thin transparent sheath closely applied to the 
dura it surrounds the cranial and spinal nerves as far as their point of exit from 
the skull and vertebral canal. 
 Pia mater: this is separated from the arachnoid by the sub arachnoid 
space, filled with cerebrospinal fluid. The pia mater closely invest the cord 
and sends delicate septa into its substance. From each lateral surface of the 
piamater a fibrous band, the denticulate ligament, projects into the 
subarachnoid space, and is attached by a serious of pointed processes to the 
dura as far down as the first lumbar nerve. Pia mater ends as a prolongation, 
the filum terminate which pierces the distal end of the dural sac and is 
attached to the periostium of the coccyx. 
 Denticulate ligaments- the denticulate ligaments are folds of the pia 
mater that extend laterally along the lines of attachment of the anterior and 
posterior roots and fuse with the arachnoid and dura mater. Structurally, they 
acts as struts to hold the spinal cord suspended within the dural space. The 
mechanical property of these ligaments is one of elasticity and is under a 
stress- stress modulus 3-5 gms.  
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NERVE SUPPLY OF MENINGES 
 The posterior aspect of the dura and arachnoid contains no nerve fibres 
and so no pain is felt on dural puncture. The anterior aspect is supplied by 
spinovertebral nerves. Each of these enters the intervertebral foramen and 
passes up for one segment and down for 2 segments. 
Spinal nerves: 
These are 31 pairs in number and are as follows: 
1. 8 cervical 
2. 12 thoracic 
3. 5 lumbar 
4. 5 sacral 
5. 1 coccygeal 
Anterior root: is efferent and motor. Sympathetic pre ganglionic axons arise 
from cells in the intermediolateral horn of the spinal cord from T1 to L2. 
Posterior root: is larger than anterior. All the afferent impulses from whole 
body including viscera pass into the posterior roots. 
 Each posterior roots has a ganglion and conveys fibers of 1.pain 
2.Tactile, 3.Thermal, 4.Deep or muscle sensation from bones, joints, tendons 
etc, 5.Afferent from the visera and 6.Vasodilator fibres. 
 The anterior and posterior roots each with its covering of pia, 
arachnoid and dura cross the extra dural space and unite in the intervertebral 
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foramina to form the main spinal nerve trunks, which soon divide into 
anterior and posterior primary divisions-mixed nerves. 
EPIDURAL SPACE 
Definition: 
 Epidural space is a potential space, ellipitical, surrounds the dural sac, 
that extends from the foramen magnum to the coccyx and laterally, 
communicates with the paravertebral space through the intervertebral 
foraminae. 
Boundaries: the epidural space is bounded superiorly by the foremen 
magnum where the periosteal and spinal layer of dura fuse, inferiorly by the 
sacrococcygeal membrane, anteriorly by the posterior longitudinal ligament 
covering the posterior aspect of the vertebral bodies and the intervertebral 
discs, posteriorly by the ligamentum flavum and the anterior surface of the 
vertebral laminae, and laterally by the pedicle of the vertebrae and the 
intervertebral foramina. 
EPIDURAL SPACE ANATOMY 
 This space is more extensive and distensible posteriorly, while in the 
anterior aspect, the dura adheres closely to the periosteum of the vertebral bodies. 
The epidural space communicates laterally with the paravertebral space through 
the intervertebral foramina. With advancing age, this communication may be 
blocked due to the increase in the connective tissue elements. 
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 To reach the epidural space in the midline sagital plane, the following 
structures are to be penetrated : 
• Skin 
• Subcutaneous tissue 
• Supraspinous ligament 
• Interspinous ligament 
• Ligamentum flavum 
 The ligamentum flavum is an important landmark for the technical 
identification of the epidural space during induction. The first three tissues 
offer little resistance to the advancing needle, but the resistance increases 
when the ligamentum flavum is reached. As the needle passes through this 
structure there is a sudden give way of the resistance. While performing 
epidural analgesia, it is important to recognize this point as little further 
advancement may result in subarachnoid penetration. 
CONTENTS OF EPIDURAL SPACES: 
 Spinal nerve roots along with their dural cuffs, they transverse the 
epidural space on their way to their respective intervertebral foramina. In the 
cervical region these travel almost horizontally, but lower down they become 
more inclined owing to the discrepancy between the length of the spinal cord 
and the spinal canal, until the lower lumbar and sacral roots are almost 
vertical. 
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 The roots vary greatly in size and thickness. The thoracic roots are 
thin, while the cervical and lumbosacral roots subserving the limbs are thick. 
The great difference in size and neural populations within the roots are 
interrelated. The very large diameter and high neural population of the dorsal 
and ventral roots of the first sacral segments are associated with great 
resistance to epidural blockade. Prolonged latency and poor analgesia of S1 
segment are due to poor penetration of local anesthetic and it deserves a 
special mention as they have an important role in the mechanism of the 
action to epidural anesthesia. 
 The arachnoid villi and granulations invaginate the epidural veins in 
the region of the dural cuff and drain the CSF from the vessels, drain the CSF 
into the epidural fat, from where it is drained by lymphatics. 
 
Fig 3. Midline Approach for Epidural Space 
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EPIDURAL VESSELS: 
 The branches of the subclavian, aortic and iliac arteries cross the 
epidural space and enter the subarachnoid space in the region of the dural 
cuffs. These branches provide blood supply as far as the spinal roots. Apart 
from the cervical region, the entire blood supply to the spinal cord passes 
through the epidural space. 
 The epidural veins are arranged in the form of longitudinal plexuses on 
either side of the line. They do not posses values. These veins although 
divided into anatomical groups, all interconnect and form a series of 
horizontal segmental anastomosis. They connect with intervertebral foramina 
and communicate with the vertebral, ascending cervical, deep cervical, 
intercostal, iliolumbar and lateral sacral veins. As the epidural veins have no 
valves they afford a connection between the pelvic veins below and the 
intracranial veins above. 
 The epidural veins become distended during coughing and straining 
and also when the inferior vena cava is obstructed by large abdominal tumors 
or in late pregnency. This distension of epidural veins diminishes the 
effective volume of the epidural space. Under these circumstances the 
requirement of the local anesthetic is markedly decreased, as a small volume 
of drugs tends to spread over a wide area in the epidural space. 
FAT: the contents of the spinal canal lie cushioned in a packet of semifluid, 
lobulated fat. Solutions injected into the epidural space, track up and down 
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between the fatty areolar tissues. The epidural fat constitutes an important 
pharmacological space and depot for injected local anaesthetics and drugs 
and it is one of the three competitors for its share of the drug. The other two 
competitors being nervous tissue of spinal roots and cords and blood vessels 
within the spinal canal. 
 Drugs with high lipid solubility and lipoprotein binding charactristics 
will tend to enter the fat phase and remain there for a period of time, 
depending on their pharmacodynamics and on the briskness of the local 
blood flow competing for uptake. The compliance of the epidural fat varies 
from person to person and with age. In children and young adults it offers 
very little resistance. 
LYMPHATICS:  
 Surrounding and draining the dural sac, lympatics run anteriorly from 
each intervertebral foramen and empty into the longitudinal channals in front 
of the vertebral column. 
 Ventrally the connective tissue is present in significant amounts, forming 
a strong connection between the dura mater and the anterior longitudinal 
ligaments in the vertebral canal. A distinct midline fold of connective tissue 
known as the plica mediana dorsalis of the duramater, extends in a longitudinal 
direction in the midline that connects the dura to the ligamentum flavum in the 
midline. These midline bands divide the epidural space into two sides, right 
and left and narrows the epidural space in the midline. 
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 The dorsomedial connection between the dura and the ligamentum 
flavum can explain some of the results occurring during clinical epidural 
anesthesia. The epidural needle must separate the dorsomedian fold during 
insertion. Insertion of a catheter may result in its disposition slightly to either 
side of the midline. When a true dorsomedian band or membrane exists, a 
patchy and/or a unilateral type of block can result. The Dorsomedian 
connections also explain the difficulty and the effort needed to advance the 
epidural catheter freely into the epidural space. 
SIZE OF THE EPIDURAL SPACE: 
Regional epidural space width and dural thickness: 
• Cervical  
• Upper thoracic 
• Lower thoracic 
• Lumbar 
IDETIFICATION OF EPIDURAL SPACE: 
a) Negative pressure methods: 
• Hanging drop technique 
• Capillary tube technique 
• Manometer technique 
b) Loss of resistance methods  
• Syringe technique 
• Spring loaded syringe technique 
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• Ballon technique 
• Brooks device technique 
• Vertical tube of Dawkins technique 
c) Other techniques: 
• Ultrasonic localization 
• And the oxford- epidural space indicator. 
 
Fig. 4.Tecnicniques to find out Epidural Space 
 
Summary of fate of injected solution in epidural space: 
 Local anesthetic or other agent injected into the epidural space may 
potentially spread as follows: superior and inferior spread is mainly in 
posterior portion of epidural space between dura and ligamentaum flavum. 
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 Superiorly the spread is to magnum. There is possibility of diffusion 
across dura at base to cerebral CSF with possibility of blockade of cranial 
nerves, vasomotor and respiratory centres and other vital centres. 
 Inferiorly to sacral hiatus, caudal canal and through anterior sacral 
foramina. Laterally through intervertebral foramina to paravertebral space, to 
produce paravertebral neural blockade. There is rapid access to CSF at dura 
cuff region to produce spinal nerve root blockade and also subsequent access 
to spinal cord. 
 Anteriorly is the thin epidural space between dura and posteriorly 
longitudinal ligament. There is also access for injection solution to CSF by 
slow diffusion into the subarachnoid space. Vascular absorption by way of 
epidural veins may convey drug directly to brain and epidural fat also takes 
up the drug. 
 The longitudinal spread in epidural space leads to: 
• Leakage by vascular absorption. 
• Leakage through intervertebral foramina – paravertebral block of nerve 
trunks in young subjects – centripetal spread – subpial spread – spinal 
root and peripheral cord block. 
• Diffusion through dural root sleeves – subdural spread – spinal root 
block. 
• Diffusion through dura mater – CSF – spinal root and pheripheral cord 
block. 
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Fig 5. Paramedian Approach for Epidural Space 
 
Factors affecting epidural spread: 
• Spread increases with age: Escape from the epidural space is relatively 
less due to the invertebral foramina being more fixed and the epidural 
vessels being less penetrable. 
• Spread is greater in pregnant ladies. 
• In arteriosclerotic patients and patients with occlusive arterial disease the 
spread is greater than normal. 
• Spread decreases in dehydration, shock and in cachexia. 
• The extent of anesthesia is greater with concentrated solutions. 
• A larger dose is required in taller individuals. 
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PHYSIOLOGICAL CONSIDERATIONS : 
 Negative pressure in the peridural space is greatest at the points of firm 
attachment. It is also greatest in the thoracic region, less in the lumbar region, 
and least or absent in the sacral area. There are two theories explaining the 
negative pressure are: 
1. The Cone Theory: This theory considers that the needle introduced into 
peridural space depresses the dura and consequently creates a larger 
epidural space. It is thus considered as an artifact caused by indentation of 
the dura by the advancing needle. 
2. The Transmission Theory: this theory considers that the negative 
pressure in the epidural space is the transmission of the intrapleural 
negative pressure via the intervertebral foramina to the peridural space. 
EFFECTS ON ORGAN SYSTEM 
Cardiovascular system :  
 Vasodilatation of resistance and capacitance vessals occurs, causing 
relative hypovolemia and tachycardia, with a resultant drop in blood pressure. 
This is exacerbated by blockade of the sympathetic nerve to the adrenal 
glands, preventing the release of catecholamines. If blockade as high as T2. 
Sympathetic supply to the heart(T2-T5) is also interrupted and may lead to 
bradycardia.  The overall result may be inadequate perfusion of vital organs 
and measures are required to restore the blood measure and cardiac output, 
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such as fluid administration and the use of vasoconstrictors. Sympathetic 
outflow extends from T1-L2 and blockade of nerve roots below this level, as 
with, for example, knee surgery, is less likely to cause significant sympathetic 
blockade, compared with procedures requiring blockade above the umbilicus. 
Respiartory system: 
 Usually unless blockade is high enough to affect intercostal muscle 
nerve supply(thoracic nerve roots) leading to reliance on diaphragmatic 
breathing alone. This is likely to cause distress to the patient, as they may feel 
unable to breath adequately.  
GIT system: 
 Blockade of sympathetic outflow(T5-L1) to the GI tract leads to 
predominance of parasympathetic (vagus and sacral parasympathetic outflow) 
leading to active peristalsis and relax the sphincters, and a small conracted gut 
which enhances surgical access. Splenic enlargement 2-3 fold occurs. 
Endocrine system: 
 Nerve supply to the adrenals is blocked leading to a reduction in the 
release of catecholamines.  
Genitourinary tract: 
  Urinary retention is a common problem with epidural anaesthesia. A 
severe drop in blood pressure may affect glomerular filtration in the kidney if 
sympathetic blockade extends high enough to cause significant vasodilatation. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Materials & Methods 
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MATERIALS AND METHODS 
  This study design is comparative study. 
   Study setting in patients undergone lower abdominal and lower limb 
surgeries under epidural anaesthesia in the department of anaesthesia in Sree 
Mookambika Institute of Medical Sciences, Kulasekharam. The study period 
was 12 months. 
  Total sample size of 70 was selected and divided into two groups 
which are described below 
Group I :  Patients receiving 15ml of 0.75% of Ropivacaine with 1 
mcg/kg of Dexmedetomidine  
Group II :  Patients receiving 15 ml of 0.75% of Ropivacaine with 1 
mcg/kg of Clonidine 
SAMPLING: 
Sample size of each group: 35 
Total sample size of the study: 70 
 Scientific basis of sample size used in the study: Formula comparative 
and descriptive study. 
 = 2
( + )

( − )

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S1 = Standard deviation of Dexmedetomidine = 3.96 
S2 = Standard deviation of Clonidine = 4.86 
Z1 = Z value associated with alpha = 1.64 
Z2 = Z value associated with beta = 0.84 
M1 = mean of Dexmedetomidine = 13.14 
M2 = mean of Clonidine = 15.8 
Sample size = 34.34 ~ 35 
sample size of Dexmedetomidine group = 35 
Sample size of Clonidine = 35 
Total sample size = 70 
S= pooled standard deviation = 4.43 
Sampling Technique: Convenient sampling.  
Inclusion criteria: 
• Patients giving valid consent. 
• Patients under ASA (American Society of Anaesthesiology) physical 
status 1 and 2 (ASA 1 – normal and healthy patients, ASA 2 – patients 
with mild systemic disease without any functional limitation. 
• Patients undergoing lower limb and lower abdominal elective surgeries 
under epidural anaesthesia. 
• Patients aged between 18-65 years of age. 
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Exclusion criteria: 
• Refusal by the patient. 
• Patients with ASA physical status 3 or more. 
• Patients posted for emergency surgeries and caesarean section. 
• Patients with history of alcohol or drug abuse. 
• Patients who are allergic to any of the test drugs. 
• Contraindication to spinal anaesthesia. 
Formulation of the drug used:  
 Dexmedetomidine hydrochloride as liquid for injection, (S)-4-[1-(2,3-
dimethyl phenyl) ethyl]-1 H-imidazole hydrochloride. Clonidine as liquid for 
injection.  
Dugs used : Dexmedetomidine, Dextomed, Neon laboratories. Clonidine  
Dose of the drug used: 1mcg/kg Dexmedetomidine with 0.75% Ropivacaine 
for epidural, 150mcg Clonidine  with 0.75% Ropivacaine for epidural  
Frequency of the drug used: a loading dose of 1mcg/kg of 
Dexmedetomidine with Ropivacaine or 1mcg/kg Clonidine with Ropivacaine 
during intraoperative period 
Route of the drug used: Epidural 
Duration of the drug used: as intraoperative. 
Steps taken to prevent adverse drug reaction): Stop the drug immediately. 
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Mode of management: Hypotension (MAP below 20% of the baseline, 
systolic pressure < 90mmHg) will be treated with incremental doses of 
Mephentermine 3mg i.v and additional RL solution as appropriate. 
Bradycardia (HR < 50bpm) will be treated with Atropine 0.6m.g i.v and 
respiratory depression (RR < 12 breaths per min) by administering 
supplemental oxygen – 4-6L/min.Inj. Hydrocortisone 100mg i.v stat, Inj. 
Pheniramine maleate 1 ampoule (45.5mg) i.m stat, Inj. Adrenaline 1:1000. 
Agreement of compensation: As per the rules of this institution. 
Registration with Clinical Trial Registry of India [CTRI]: Yes, 
registration copy attached herewith. 
Clinical trial design: comparative and descriptive study. 
Clinical trial done at: single site 
Allocation ratio of different groups: 1:1 
Randomization: Yes 
Type of randomization: randomized control trial 
Method used to generate random sequence numbers: randomized 
purposive sampling technique 
Allocation concealment mechanism: not applicable 
Type of blinding used: this is a comparative, descriptive study 
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Parameters to be studied: heart rate per min, Blood pressure in mmHg, 
SpO₂ in percentage. 
Instruments used: Multiparameter, Schiller, made in Switzerland-India. 
Procedure in brief: 
 After approval of the study protocol by our institutional committee, 
written informed consent will be taken from each patient. ASA status I and II 
patients of either sex, aged between 18-65 years, weighing 50-70kgs, 
undergoing lower limb or lower abdominal surgery under epidural anaesthesia 
will be enrolled in this study. All the patients will be visited on the day prior 
to surgery, explained in detail about the anaesthetic procedure and informed 
written consent will be obtained.  
 The patients will be kept nil orally 6hrs prior to the day of surgery. 
Patients with a history of alcohol or drug abuse, diabetes mellitus, cardiac 
cases, hypertension, COPD, psychological disease, hepatic and/or renal 
disease, spinal deformities or any contraindication to spinal anaesthesia (for 
eg: coagulation defects, infection at the puncture site, pre-existing 
neurological deficits in the body, etc.) and patients allergic to amide type of 
local anaesthetics are excluded from the study. 
 On arrival to the operation theatre, following insertion of an 18-G 
venous cannula, 500mL of Ringer Lactate was infused to the patient before 
epidural anaesthesia. Standard monitors like ECG, Non-invasive Blood 
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Pressure and SpO₂ probe was attached and baseline parameters recorded and 
Inj. Ranitidine 50mg i.v and Inj. Metoclopramide 10mg slow i.v half an hour 
before the surgery. Group I was given Dexmedetomidine 1mcg/kg with 
Ropivacaine epidurally, whereas Group II will be given 1mcg/kg of Clonidine 
with Ropivacaine epidurally. Patients will then be positioned and 15ml  
0.75%  Ropivacaine  was administered epidurally  in L3-L4  interspace 
through a standard midline approach using a 18-G tuohy needle and all 
patients will be supplemented with oxygen - 4L/min via a face mask 
throughout the procedure after positioning the patient. Sensory block will be 
assessed using sterile pin prick method in the mid-axillary line on both sides 
of the chest, motor block was assessed using a modified Bromage scale (grade 
0 ⇾ no paralysis; grade I ⇾ unable to raise extended leg; grade 2 ⇾ unable to 
flex the knee, grade 3 ⇾ unable to flex the ankle) 
 Sensory and motor block was assessed every minute for the first 10mins 
and thereafter every 10mins during the surgery and every 15mins 
postoperatively and be recorded. The highest dermatome level of sensory 
blockade and motor blockade will be recorded. Recovery time for the sensory 
blockade is considered as two dermatome regression of anaesthesia from the 
maximum level; motor block duration is the time to return to grade 1on the 
modified Bromage scale. Postoperative pain was assessed by using the Visual 
Analog Scale (VAS 0 ⇾ no pain and VAS 10 ⇾ worst possible pain) at 4, 8, 12 
and 24 hour. Patients with a VAS score of 3 or more was given Inj. Tramadol 
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50mg slow i.v.  The time of patient’s first request for postoperative analgesia 
after the surgery was recorded as duration of postoperative analgesia. 
 The Ramsay sedation score was used to assess sedation (1⇾ Anxious or 
agitated; 2⇾ co-operative and tranquil; 3⇾ drowsy, but responsive; 4 ⇾asleep, 
but responsive to glabellar tap; 5⇾ asleep with a sluggish response to tactile 
stimulation and 6⇾ asleep, with no response). The score was re-evaluated 
every 10mins after the administration of the drug for up to 180mins and every 
15mins thereafter. Score 5/6 will be considered as excessive sedation. 
 The vital data viz. heart rate (HR), mean arterial pressure (MAP), 
oxygen saturation (SpO₂), respiratory rate (RR) was recorded  immediately 
before and 60secs after dural puncture, every 10mins after epidural 
anaesthesia intraoperatively and every 15mins in the postoperative period. 
STATISTICAL ANALYSIS:   
1. The study parameter was entered in Microsoft excel work sheet 2013 
version and data was analysed by using statistical package of social 
science(SPSS) trial version 20.0 
2. Test of significance used – student t test 
3. Level of confidence is 95%. 
4.2 ASSESSMENT OF  PARAMETERS 
 Onset of sensory analgesia was defined as time taken to achieve loss of 
pain sensation at T10 dermatome level from the end of injection of the study 
drug. This was evaluated by using pin prick along the mid axillary line at 
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every minute till onset of block at T10. 
       Duration of analgesia is defined as the time taken from the onset of 
sensory blockade at the T 10 level to the time of sensation of pain at the 
surgical site with a VAS score of >3. 
 Peak sensory level was defined as the highest dermatome level of 
sensory blockade achieved after administration of study drug. 
 Time to two dermatome regression was defined as the time interval 
from the sensory block at the highest dermatome to the regression of sensory 
blockade by two dermatomes. The sensory level was assessed every 
15minutes after 2 hours of epidural bolus injection till 2 dermatome 
regression of sensory level was observed. 
 The time to motor blockade was defined as the time interval from the 
administration of epidural study drug to the achievement of grade 3 motor 
blockade in the lower limbs. 
 The degree of motor block was assessed using the modified Bromage 
scale. 
 The assessment for motor block was done every 5 minutes after 
administration of study drug till a block of modified Bromage grade 3 motor 
blockade was achieved. 
 The level of sedation was assessed 10minutes after grade 3 motor 
blockade and at the end of surgery based on the Ramsay sedation scale. 
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 Hemodynamic parameters were monitored every 5 minutes for the first 
30 minutes, every 10 minutes thereafter till the end of surgery. Patient 
received inj. Atropine 0.6 mg when the heart rate fell below 20%of baseline 
(bradycardia) and Inj. Mephentermie in titrated bolus when there was 
hypotension (fall below 20% of baseline). Any side effects seen after 
administration of study drug was noted and treated appropriately. Patient 
scheduled for lower abdominal and lower limb surgeries limb surgeries 
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RESULTS 
 The study group consisted of 70 patients, 35 in group RC who received 
15ml of 0.75% of Ropivacaine with 1mcg/kg Clonidine and 35 in group RD 
who received 15ml of 0.75% of Ropivacaine with 1mcg/kg 
Dexmedetomidine. Both groups were comparable demographically with 
respect to age and age distribution, height & weight characteristics. The 
distribution of the types of surgery and the duration of surgery was 
comparable between the two groups.  
 The onset of sensory blockade was found to be significantly shorter in 
the RD group along with a prolonged duration of the action (p<0.005). There 
was no significant difference found between the two groups in terms of onset 
of motor blockade and hemodynamic changes. Both groups had a similar 
incidence of hypotension and bradycardia which was not found to be 
significant. The side effects in both groups were minimal and comparable 
between the two groups.  
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DEMOGRAPHIC PROFILE 
Table 1 Gender Distribution 
Gender 
Category 
Total 
Group 1 Group 2 
N % N % N % 
Male 25 71.4 21 60.0 46 65.7 
Female 10 28.6 14 40.0 24 34.3 
Total 35 100.0 35 100.0 70 100.0 
p=0.314 
 
 
 
 
Fig 6. Gender Distribution 
 
 
 
 Gender between the 2 groups. The group RC had males of 71.4±60 and 
the group RD had  females of 28.6±40. There was no significant difference in 
the gender composition between the two groups. (p=0.314) 
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Table 2  ASA Physical Status Distribution 
 
ASA 
Category 
Total 
Group 1 Group 2 
N % N % N % 
Grade 1 25 71.4 27 77.1 52 74.3 
Grade 2 10 28.6 8 22.9 18 25.7 
Total 35 100.0 35 100.0 70 100.0 
p=0.299 
 
 
 
Fig 7.ASA Physical Status Distribution 
 
 ASA grading between the 2 groups. The group RC had ASA1 of 
71.4±77.1 and the group RD had ASA2 of 28.6±22.9. There was no 
significant difference in the ASA grading between the two groups. (p=0.299) 
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Table 3 Weight Distribution 
  
N 
Weight in Kg 
T P 
Mean sd 
Group 1 35 61.14 9.239 
1.199 0.235 
Group 2 35 58.63 8.282 
 
 
 
 
Fig 8. Weight Distribution 
 
 
 Weight of persons in the group RC had a mean weight is  61.14±9.239 
and the group RD had a mean weight is 58.63±8.282. 
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Table 4  Height Distribution 
 
 
N 
Height in cm 
T P 
Mean SD 
Group 1 35 160.26 6.279 
1.478 .144 
Group 2 35 155.74 16.949 
 
 
 
 
Fig 9. Height Distribution 
 
  
 Height of persons in the group RC had a mean height of 160.26±6.276 
and the group RD had a mean height of 155.74±16.979.  
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Table 5 Age Distribution                                   
 
N 
Age in years 
t P 
Mean SD 
Group 1 35 41.00 9.133 
-1.946 
 
.056 
 Group 2 35 45.20 8.924 
 
 
 
 
Fig 10. Age Distribution 
 
 
 Person between the ages 18 years to 65 years were included in this 
study. The group RC had a mean age of 41.00 ± 9.133 years and the group RD 
had a mean age of 45.20 ±8.924 years. The standard error was 1.78 in group 
RC and 1.65 in group RD. there was no significant difference in the age 
composition between the two groups. (p=0.07) 
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Table 6 Distribution of Surgery 
Surgery 
Category 
Total 
Group 1 Group 2 
N % N % N % 
HER 20 57.1 19 54.3 39 55.7 
POP 2 5.7 0 0.0 2 2.9 
TIBIA 1 2.9 1 2.9 2 2.9 
VH 12 34.3 15 42.9 27 38.6 
Total 35 100.0 35 100.0 70 100.0 
p=0.501 
 
Fig 11. Distribution of Surgery 
 
 
 Both groups had patients undergoing hernioplasty, vaginal 
hysterectomies and lower limb surgeries. There was no significant difference 
between the two groups in terms of distribution of types of surgery, p value 
=0.501.  
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Table 7 Duration of Surgery 
 
N 
Duration 
t P 
Mean SD 
Group 1 35 84.00 27.675 
-1.796 .077 
Group 2 35 95.00 23.389 
 
 
 
 
Fig 12.  Duration of surgery 
 
 
 The mean duration of surgery in group RC is 84.00±27.675 and 
standard error of 4.31 and in the group RD is 95.00 ±23.389 and standard 
error of 4.38. The difference was statistically not significant(p=0.260) 
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Table 8  Efficacy of the drug 
 
N 
T10 
t P 
Mean SD 
Group 1 35 12.00 1.970 
7.916 <0.001 
Group 2 35 8.51 1.704 
 
 
 
 
Fig 13. Efficacy of the drug 
 
 
 The mean time to onset on sensory blockade in group RC was 12.00 
±1.970 minutes and in group RD was 8.51 ±1.704 minutes. The difference 
was found to be statistically significant with a p=<0.001. 
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Peak level of sensory blockade 
 The highest level achieved in the two groups was T5, which was 
achieved in 5.7% of patients in the RC group and 37.1% of patients in the RD 
group. T6 level of sensory blockade was seen in 80.0% in the RC group and 
60.0% in the RD group. The difference between the two groups is statistically 
significant with p=0.003 
Table 9 Peak level of sensory blockade 
PEAK 
Category 
Total 
Group 1 Group 2 
N % N % N % 
T5 2 5.7 13 37.1 15 21.4 
T6 28 80.0 21 60.0 49 70.0 
T8 5 14.3 1 2.9 6 8.6 
Total 35 100.0 35 100.0 70 100.0 
p=0.003 
 
 
Fig 14.  Peak level of sensory blockade 
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Table 10 Time to complete Motor Blockade (Motor Grade 3) 
 
N 
MG_3 
t P 
Mean SD 
Group 1 35 23.20 4.523 
.195 .846 
Group 2 35 23.00 4.058 
 
 
 
Fig 15. Time To Complete Motor Blockade 
 
 Maximum motor blockade was achieved in 23.20±4.523 minutes in 
group RC and 23.00± 4.058minutes in group RD. There was no statistical 
difference between the two groups in the onset of complete motor block with 
p value of 0.846. 
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Table 11 Duration of Blockade-Time to Rescue Analgesia 
 
N 
Duration 
T P 
Mean SD 
Group 1 35 275.14 40.520 
-4.935 <0.001 
Group 2 35 316.86 29.308 
 
 
 
Fig 16. Duration of blockade - time to rescue analgesia 
 
 
 The mean duration of sensory blockade in the group RC was 
275.14±40.52minutes and in group RD was 316.86±29.308minutes. There 
was a statistically significant difference in the duration of blockade between 
the two groups with a p value of <0.001. 
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Table 12  Time To 2 Dermatome Regression 
 
N 
2DERM 
t P 
Mean SD 
Group 1 35 137.00 20.227 
-5.762 <0.001 
Group 2 35 161.43 14.831 
 
 
 
Fig 17. Time to 2 dermatome regression 
 
 
 The time to two dermatome regression of sensory blockade in group 
RC was 137 ±20.227 minutes and in group RD was 161.43 ±14.831 minutes. 
This difference between the two groups was found to be statistically 
significant. (p=<0.001). 
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Table 13 Sedation Score at 10 Minutes 
SE_10 
Category 
Total 
Group 1 Group 2 
N % N % N % 
2 24 68.6 0 0.0 24 34.3 
3 11 31.4 22 62.9 33 47.1 
4 0 0.0 13 37.1 13 18.6 
Total 35 100.0 35 100.0 70 100.0 
p<0.001 
 
 
Fig 18. Sedation score at 10 minutes 
 
 Sedation was assessed 10minutes after motor grade 3 blockade using 
Ramsay sedation score. 24 out of the 35 cases (68.6%) in group RC had a 
score of 2 while 22 out of 35 cases (62.9%) in group RD had a sedation score 
of 3. The difference in the sedation between the two groups was found to be 
statistically significant. (p=<0.001). 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Group 1 Group 2
SE 10
4
3
2
   Results 
71 | P a g e  
 
Table 14 Sedation Score at the end of surgery 
 
Category 
Total 
 
Group 1 Group 2 
SED_END N % N % N % 
2 25 71.4 0 0.0 25 35.7 
3 10 28.6 33 94.3 43 61.4 
4 0 0.0 2 5.7 2 2.9 
Total 35 100.0 35 100.0 70 100.0 
p<0.001 
 
' 
Fig 19. Sedation Score at the end of surgery 
 
 Sedation score was assessed at the end of surgery and it was found that 
25 out of the 35 cases (71.4%) in group RC had a score of 2 while 33 out of 
35 cases (94.3%) I a group RD had a sedation score of 3. The difference in the 
sedation between the two groups was found to be statistically significant. 
(p=<0.001) 
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Table 15 Changes in heart rate over time 
Heart rate 
Group 1 (N=35) Group 2 (N=35) 
 
t 
 
P mean sd mean sd 
0 minute 77.40 8.222 79.49 10.472 -.927 .357 
5 minute 76.57 9.319 78.49 10.752 -.796 .429 
10 minute 72.34 9.152 70.89 9.380 .658 .513 
15 minute 66.46 13.611 67.29 8.191 -.309 .759 
20 minute 64.43 6.984 62.57 7.072 1.105 .273 
25 minute 61.37 7.166 60.86 6.779 .308 .759 
30 minute 60.03 6.506 58.23 7.581 1.066 .290 
40 minute 60.60 6.779 57.66 6.633 1.836 .071 
50 minute 60.91 7.164 57.14 6.731 2.270 .026 
60 minute 59.06 5.810 58.23 6.695 .553 .582 
70 minute 61.31 8.025 57.43 5.468 2.367 .021 
80 minute 59.17 5.591 57.57 5.164 1.244 .218 
90 minute 56.20 7.136 57.60 4.894 -.957 .342 
100 minute 56.94 6.145 57.54 6.075 -.411 .683 
110 minute 57.03 7.115 58.09 5.564 -.692 .491 
120 minute 56.03 6.066 57.80 4.378 -1.401 .166 
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Fig 20.  Changes in heart rate over time 
 
 There was a significant fall in heart rate by 20% between 30 to 50 
minutes of epidural injection in both groups; however there was no significant 
difference in the fall of  heart rate between the two groups.(p=0.592) 
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CHANGES IN MEAN ARTRIAL PRESSURE IN OVER TIME 
 There was a significant fall in the mean arterial pressure by 25% 
between 40 to 50 minutes in both groups, however there was no significant 
difference in the occurrence of hypotension between the two groups. 
(p=0.796). 
SIDE EFFECTS 
Doses of Atropine used: 
 The incidence of bradycardia was found to be similar in both groups 
and showed no statistical significance. The requirement of one dose of 
Atropine was 36.6% and 16.7% in group RC and RD and two doses in 3.3% 
and 20% I RC and RD groups respectively. There was no statistically  
significant difference between the two groups in term of bradycardia requiring 
Atropine (p=0.054).  
Doses of mephentermine: 
 There was no significant difference in the occurrence of hypotension in 
both groups. The requirement of one dose of Mephentermine was 26.7% and 
30% in group RC and RD groups respectively. There was no statistically 
significant difference between the two groups in term of hypotension 
requiring Mephentermine(p=0.774). 
Other side effects: 
 There were three cases with dry mouth, two in the RC and one in the 
RD group no other side effects were observed during the period of our study. 
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DISCUSSION 
 Epidural anaesthesia is considered as a gold standard technique as it 
provides complete, dynamic anaesthesia and post operative analgesia. The 
benefits include suppression of stress response by sympatholysis, stable 
hemodynamics with reduction in cardiac morbidity, reduction in pulmonary 
complications due to active physiotherapy and early mobilization, reduced 
blood loss and decrease in thromboembolic complications following 
surgery[1,2,5] 
 Sara et al (6) compared the characteristics of 0.75% Ropivacaine and 
0.5% Bupivacaine and concluded that Ropivacaine and Bupivacaine at these 
doses produced equally effective anaesthesia. 0.75% Ropivacaine produce 
adequate intensity of motor and sensory blockade and its comparable to 
0.5% Bupivacaine with reduced side effects. Hence we used 0.75% 
Ropivacaine to provide epidural anaesthesia. 
 Dexmedetomidine is known to have eight times more affinity than 
Clonidine for alpha adrenergic receptors, however there are no studies 
documenting the equivalent doses of epidural Dexmedetomidine and 
Clonidine(18,32,33) A number  of studies have used epidural Clonidine at doses 
of 1-4mcg/kg ,and it has been noted that the hemodynamic side effect are 
dose dependent. It has been suggested that epidural Clonidine at a dose 
1mcg/kg prolongs analgesia without producing unwanted side effects. 
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 Epidural Dexmedetomidine has been studied at doses ranging from 1-
2mcg/kg and it was observed that at doses less than 1mcg/kg 
Dexmedetomidine does not prolong the block of Ropivacaine. Hence in our 
study, we have used equal concentration of 1mcg/kg of Clonidine and 
Dexmedetomidine as an adjuvant to Ropivacaine in epidural anaesthesia. 
 In this study, we compared two alpha agonists Clonidine and 
Dexmedetomidine with 0.75% Ropivacaine in the epidural route for lower 
abdominal and lower limb surgeries. The study was conducted in 70 patients 
between the ages of 18 to 65 years who were randomly assigned into two 
groups. Group RD received 15ml f 0.75% Ropivacaine with 1mcg/kg of 
Dexmedetomidine and group RC received 15ml of 0.75% Ropivacaine with 
1mcg/kg of Clonidine, both groups received a total volume of 15+ml. 
 The demographies of both groups were found to be comparable with 
respect to age, gender, height, weight & surgery duration as there was no 
statistically significant difference(p>0.05)  
Onset of blockade: 
 Our study showed significantly earlier onset of sensory blockade in 
the patient receiving Dexmedetomidine (8.53±1.81minutes) when compared 
to the patients receiving Clonidine (11.93±1.96 minutes). There was 
significantly higher dermatomal spread in group RD. this findings was 
consistent with the previous observations made by Bajwa et al11, who found 
that the onset of sensory analgesia at T10 was faster in the group receiving 
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Dexmedetomidine (8.52±2.36min)when Compared to ten patients receiving 
Clonidine (9.72±3.44min) and there  was also associated with a faster and 
higher level of sensory blockade . It has been observed that when 
Dexmedetomidine is administrated epidurally it reaches a maximum 
concentration in the CSF within 5 minutes with a distribution half life of 0.7 
minutes. There is a dose dependent anti nociceptive effect of epidural 
Dexmedetomidine which has been associated to its affinity for the alpha 2 
receptors on the spinal cord.   
 Dexmedetomidine also has higher lipid solubility in comparison to 
Clonidine. This may be the probable cause for the enhanced potency of 
epidural Dexdemetomidine over Clonidine.  
Duration of analgesia 
 In this study we found that the duration on sensory analgesia was 
more in group RD (316±31.15minutes) than group RC (281 ± 37 minutes) 
which was statistically significant (p=0.000). In the study done by 
Sukminder Jit Singh Bajwa et al22 , they found a significantly longer time to 
first rescue top up in the Dexmedetomidine group(342.88 ± 29.16minutes) 
than the Clonidine group (310.76± 23.76 minutes). This may be because 
they had also used onset of incisional pain to indicate analgesia time, 
however the higher doses of Dexmedetomidine (1.5mcg/kg) and Clonidine 
(2mcg/kg) may be considered to explain the prolonged duration in 
comparison to our study. 
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 Mausumi Neogi et al studied the characteristics of Clonidine 
(1mcg/kg) & Dexmedetomidine (1mcg/kg) with 0.25% Ropivacaine when 
given caudally for post operative analgesia in children & found that the 
mean duration of analgesia was not significantly prolonged between the 
groups receiving Clonidine (13.17 ±0.68 hours)  & Dexmedetomidine 
(13.17± 0.68hours). In their study caudal analgesia was given as an adjuvant 
to general anaesthesia & CRIES score of 4 above was used to denote the 
duration of analgesia. 
Motor blockade 
 We found no statistically significant difference time to complete 
motor blockade, between the two groups, group RD in 23.00 ± 4.27 minutes 
& group RC in 23.07± 4.63 minutes). Bajwa et al22 found that patients 
receiving Dexmedetomidne (17.24± 5.16minutes) achieved grade 3 motor 
blockade in less time than those receiving Clonidine (19.52 ± 4.06) as an 
adjuvant . This may be attributed to the larger doses of Dexmedetomidine 
(1.5mcg/kg) & Clonidine (2mcg/kg) used in their study.  
Sedation 
 In this study, we found better sedation in the patients who received 
Dexmedetomidine that those who received Clonidine at both 10 minutes and 
at the end of surgery. This apparent change was also found to be statistically 
significant (p=0.000). 
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 The similar study conducted by Oriol-Lopez et al,26 assessing the 
anxiolytic and sedative property of epidural Dexmedetomidine in patients 
undergoing abdominal surgeries, Dexmedetomidine was given at a dose of 
1mcg/kg. Following the injection, Ramsay sedation score was used for 
assessment of sedation. They found that 90% of the patients receiving 
Dexmedetomidine were sedated to a score of 3 to 4 for 90minutes after drug 
administration. 
 The findings of Bajwa et al32, also showed a significantly higher level 
of sedation in the patients who received Dexmedetomidine in comparison to 
Clonidine.  
 These findings from the studies mentioned above concur with the 
findings from our study, showing that Dexmedetomidine causes significantly 
higher sedation that Clonidine when given epidurally. 
Hemodynamic changes: 
 We found that heart rate significant fell in both the group by 20 in 30 
to 50 minutes after the epidural injection. Blood pressure decreased by 25% 
in 30 to 50 minutes following epidural injection. However, this change was 
not statistically significant (p>0.05) 
 Similar observations were observed by Bajwa et al and Schnaider et 
al 34 where a 15% fall of heart rate % blood pressure from the baseline which 
was not statistically significant. 
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Side effects: 
 We observed similar hemodynamic changes in both the study groups. 
We found no significant difference in the Atropine & Mephentermine 
requirement as a rescue I both the groups. Findings were similar to studies 
done by Bajwa et al32 & Sarita Swami et al who also found no significant 
difference in terms of hypotension & bradycardia between the patients 
receiving Dexmedetomidine or Clonidine. 
 Nausea, vomiting and shivering was not observed in both the groups. 
We had two patients in group R and one patient in group RD who had dry 
mouth. The study conducted by Bajwa et al showed a higher incidence of 
nausea, dry mouth during the postoperative period. 
 The limitations of our study was that as different surgeries were taken 
up in this study, therefore onset of pain at surgical incisional site may not 
give an accurate duration of analgesia. There is also need for larger studies, 
using different concentration of both drugs to find equivalent doses of 
epidural Dexmedetomidine and Clonidine. There is a further requirement to 
assess the long term safety and effects of epidural Dexmedetomidine as most 
studies only determine the short term effects. 
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CONCLUSION 
 We conclude that the addition of 1mcg/kg Dexmedetomidine as an 
adjuvant to 0.75% Ropivacaine in epidural anaesthesia causes an early onset 
and prolonged duration of sensory analgesia in comparison to 1mcg/kg 
Clonidine. Epidural dexmedetomidine cause better sedation as compared to 
Clonidine.  
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CONSENT FORM 
PART 1 OF 2 
Dear volunteers, 
 We welcome you and thank you for your keen interest in participating in this 
research project. Before you participate in this study, it is important for you to 
understand why this research is being carried out. This form will provide you all the 
relevant details of this research. It will explain the nature, the purpose, the benefits, 
the risks, the discomforts,theprecautions and the information about how this project 
will be carried out. It is important that you can read and understand the contents of 
the form carefully. This form may contain certain scientific terms and hence, if you 
have any doubts or if you want more information, you are to ask the study personnel 
or the contact person mentioned below before you give your consent and also at any 
time during the entire course of the project. 
 
1. Name of the Principal Investigator :  Dr. B.M.Sathesh Kumar 
   Postgraduate – M.D Anaesthesiology 
   Sree Mookambika Institute of Medical 
Sciences, 
   Kulasekharam 
 
2. Name of the Guide :  Dr. Thavamani 
   Professor& HOD 
   Department of Anaesthesiology 
   Sree Mookambika Institute of Medical 
Sciences, 
   Kulasekharam 
 
3. Name of the Co-Guide : Dr. Rommy Geever.T 
   Asst. Professor 
   Department of Anaesthesiology 
   Sree Mookambika Institute of Medical 
Sciences, 
   Kulasekharam. 
 
4. Institute: Details with Address : Sree Mookambika Institute of Medical 
Sciences, 
   Kulasekharam 
   Kanyakumari District – 629161 
   Tamil Nadu 
 
 
5. Title of the study:  
“Dexmedetomidine versus  Clonidine as an adjuvant to 0.75% Ropivacaine for 
epidural anaesthesia in lower abdominal and lower limb surgeries in tertiary care 
centre – A comparative study”. 
 
6. Background information: 
A prospective randomised study was carried out to evaluate the efficacy of 
epidural route and to compare the efficacy and clinical profile of dexmedetomidine 
and clonidine as an adjuvant to ropivacaine, in epidural analgesia with special 
emphasis on their quality of analgesia and the ability to provide the smooth post-
operative course to prolong the postoperative analgesia. Dexmedetomidine have 
been the focus of interest for its sedative, analgesic, perioperative sympatholytic, 
anaesthetic-sparing, and haemodynamic-stabilizing properties while still 
maintaining patient arousability with little or no respiratory depression. 
 
7. Aims and Objectives 
• To study the comparision of Dexmedetomidine and Clonidine as an adjuvant 
to 0.75% Ropivacaine for epidural anaesthesia in lower abdominal and lower 
limb surgeries  
 
8. Scientific justification of the study: 
The sole essence of anaesthesia is pain relief in intra and postoperative 
period. Regional anaesthesia has emerged as an important technique, with 
simplicity, effectiveness and safety as its added advantages. 
 Epidural anaesthesia has many advantages like easy to perform, slow onset 
of action and good muscle relaxant. Dexmedetomidine is a potent and highly 
selective ₂ - adrenoreceptor agonist. It exerts analgesic, sedative and anxiolytic 
effects after epidural administration. Dexmedetomidine administered epidurally. 
Though it has a short duration of action, is a valuable adjunct during surgery 
because of its anaesthetic and analgesic sparing effects. It also improves intra- 
and post-operative haemodynamic stability by reducing the release of 
norepinephrine thereby attenuating the increase in systemic vascular resistance 
and has minimal or no respiratory depression. Its haemodynamic effects are 
predictable and dose-dependent. An epidural dose  of 0.2 to 0.7mcg/kg/hr 
produces effective sedation and reduces the analgesic requirements. The sedative 
effect is rapid and stable; maintains patient arousability and anxiolysis. 
Dexmedetomidine possesses cardio-protective properties that could benefit 
surgical patients at high cardiovascular risk. 
This study is designed to evaluate the effects of giving  
Dexmedetomidine and  Clonidine as adjuvants in 0.75% Ropivacaine  for lower 
abdominal and lower limb surgeries. 
 
9. Procedure of the study: 
Epidural anaesthesia has different steps. Patient will first be preloaded 
with 500mL of RL through 18G cannula, premedication will be given with Inj. 
Ranitidine 50mg i.v, Inj. Metoclopramide 10mg slow i.v and Group I will be 
given 0.75% Ropivacaine + Dexmedetomidine 1 mcg/kg  and Group II – 15mL 
of 0.75% Ropivacaine+clonidine1 mcg/kg. The Multiparameter monitors will be 
attached and the heart rate, blood pressure and oxygen saturation will be 
constantly recorded from the time of administration of premedication and 
continued postoperatively. 15ml of 0.75% Ropivacaine will be administered 
epidurally into L2-L3 intervertebral space after proper positioning of the patient 
and the sensory and motor block, sedation score and postoperative analgesia will 
be assessed throughout for the study purpose. 
 
10. Expected risk of the participants: 
Tachycardia/bradycardia and/or hyper/hypotension 
 
11.  Expected benefits of the patients: 
Adding Clonidine or Dexmeditomidine may improve the quality of pain 
relief and may provide comfortable sedation to the patient and also this study 
will be beneficial for the betterment of health science. 
 
12. Maintenance of Confidentiality: 
All data collected for the study will be kept confidentially and would 
reflect on general statistical evaluation only and would not reveal any personal 
details. 
 
13. Why have you been chosen to be in the study? 
You are undergoing epidural anaesthesia and fulfill the inclusion and 
exclusion criteria of the study. 
 
14.How many people will be in the study? 70 
 
15.Agreement of compensation to the patient: In case of drug related injury, the 
patient will be treated in the hospital as per CDSO regulation; compensation amount 
will be decided by IHEC regulation. 
 
16. Anticipated prorated payment, if any, to the participant(s) of the study: Nil 
 
17. Can I withdraw from the study at any time during the study period? Yes 
 
18. If there is any new findings / informations, would I be informed?  : Yes 
19. Expected duration of Participant’s participation in the study: throughout the 
surgery 
 
20. Any other pertinent information: No 
 
21. Whom do I contact for further information? : Dr. B.M.Sathesh Kumar 
 
 
 
For any study related queries, you are free to contact 
Dr. B.M .SATHESH KUMAR 
Postgraduate – M.D Anaesthesiology 
Department of Anaesthesiology 
Sree Mookambika Institute of Medical Sciences, 
Kulasekharam 
Mobile number: +919787000011 
e-Mail I.D: drsatheshbm@gmail.com 
 
 
 
 
Place: 
Date:      
 Signature of the Principal Investigator 
 
 
 
 
Signature of the Participant 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONSENT FORM 
PART 2 OF 2 
PARTICIPANT’s CONSENT FORM 
 
The detail of the study has been explained to me in writing and the details have been 
fully explained to me. I am aware that the results of the study may not be directly 
beneficial to me but will help in the advancement of medical science. I confirm that 
I have understood the study and had the opportunity to ask questions. I understand 
that my participation in the study is voluntary and that I am free to withdraw at any 
time, without giving any reason. Without the medical care that will normally be 
provided by the hospital being affected. I agree not to restrict the use of any data or 
results that arise from this study provided such a use is only for scientific purpose(s). 
I have been given an information sheet giving details of the study. I fully consent to 
participate in the study titled “Dexmedetomidine and Clonidine as an adjuvant to 
0.75% Ropivacaine for epidural anaesthesia in lower abdominal and lower limb 
surgeries in a tertiary care centre- Comparitive study.” 
 
Serial no:/Reference no: 
Name and address of the Participant:      
 
 
Contact Number of the Participant: 
 
 
 
 Signature / Thumb impression of the participant / Legal Guardian 
 
 
 
Witnesses: 
1. 
 
2. 
 
Date: 
Place: 
 
 
 
 
SREE MOOKAMBIKA INSTITUTE OF MEDICAL SCIENCES 
PADANILAM, KULASEKHARAM - 629161 
CASE RECORD FORM 
 
PROFORMA FOR ANAESTHESIA RECORD 
Pre-Anaesthetic Evaluation 
Date: 
Name of the patient:      Age/Sex: 
Address:       I.P No: 
 
History From: 
Surgical Diagnosis: 
Proposed Surgery: 
Previous Anaesthesia: 
Relevant Past History:  (Respiratory/Cardiovascular/Hepato/Gastrointestinal/ 
Neuro/Musculoskeletal/Renal/Others if any) 
Current Medications (if any): 
Known Allergies: 
General Physical Examination: (Good/Fair/Sick/Conscious/Drowsy/Unconscious) 
Pulse rate:    Blood Pressure:    Pallor: 
Cyanosis:    Temperature:   Edema: 
Height (cms):       Weight (kgs): 
Airway: M.P   T-M distance:   M-O distance:  
Neck Movements: full/limited/none  Teeth: (poor/loose) Micrognathia:  
Short muscular neck:   Morbid Obesity:  Others: 
 
Examination Findings: 
 
Pulmonary Examination:     (smoker/not) 
 
 
Cardiovascular Examination: 
 
 
Abdominal Examination:     (alcoholic/not) 
 
 
Neuro-muscular Examination: 
 
 
ECG: 
 
X-ray Chest: 
 
ECHO/TMT/Others: 
 
 
 
 
 
 
 
 
 
 
INVESTIGATIONS AND LABORATORY REPORTS 
 
Hemoglobin:      LFT: 
TC:       Serum Bilurubin: 
DC:       Direct Bilurubin: 
ESR:       Indirect Bilurubin: 
Blood Sugar: Fasting:     SGOT: 
     Post-prandial:   SGPT: 
     Random:    SAP: 
Blood Urea:      S. Protein: 
Serum Creatinine:     Total Protein: 
Blood Group and Rh factor:    Albumin Globulin ratio: 
Urine Routine:           BT: 
       CT: 
Serology:      Others: 
 
ASA Physical Status: 1 2 3 4 5 6 E 
Patient accepted for Anaesthesia: Yes/No 
Planned Anaesthesia Technique: 
Pre-medications and Instructions: 
 
 
 
 
 
Name of the Anaesthesiologist:    Signature  
 
Anaesthesia Record 
        Date: 
Name of the Patient:      Age/Sex: 
        I.P No: 
Anaesthesiologist:      Surgeon: 
Procedure:       Position: 
Pre-procedure: 
 Consent signed:    Chart Reviewed: 
 NPO since:    Full stomach:  
 Patient reassessed prior to anaesthesia:  
Pre-anaesthetic state: (Awake/calm/anxious/uncooperative/sedated/unconscious) 
Pre-procedure vitals: Pulse rate:    Blood Pressure: 
 Respiratory rate:      Temperature: 
 SpO₂: 
Anaesthesia machine checked: Eye care:   Pressure points checked Critical 
Clinical Alarms checked & activated:    and padded 
Monitors and Equipment: 
Non-invasive B.P :      Continuous ECG:                          Pulse Oximeter: 
 
Anaesthetic Technique: 
 Position of the patient:    Needle Type and size: 
 Site: 
 Drug:       Dose: 
IV Fluids: 
Medications used intraoperatively: 
Urine output: 
Intraoperative Vitals monitoring: 
Symbols used: B.P: Systolic:  Diastolic:  MAP: 
      Pulse rate:  Respiratory rate: 
 
 SpO₂                      
Temperature                      
200                      
                      
180                      
                      
160                      
                      
140                      
                      
120                      
                      
100                      
                      
80                      
                      
60                      
                      
40                      
                      
20                      
                      
 
Sensory 
Block/Dermatome 
level 
                     
Motor Block level                      
VAS 
 
                     
Ramsay Sedation 
Score                      
 
Postoperative status of the patient: 
B.P:    Pulse rate:   Temperature:  
 SpO₂: 
Postoperative instructions: 
MASTER CHART  
GROUP I 
Sl. No AGE GENDER WEIGHT HEIGHT ASA SURGERY DURATION T10 PEAK 2DERM MG_3 DURATION SE_10 SED_END HR0 HR5 HR10 HR15 
1 58 1 63 172 1 HER 75 10 T6 135 25 270 2 2 61 63 61 56 
2 43 1 57 160 1 HER 70 15 T6 160 25 295 2 2 85 75 82 83 
3 30 1 52 154 1 HER 90 8 T5 150 30 250 2 2 56 62 60 62 
4 35 2 53 152 1 VH 90 12 T6 110 15 260 2 2 82 80 76 76 
5 44 1 50 165 1 HER 70 12 T8 100 20 280 3 3 82 80 78 62 
6 53 2 56 156 2 VH 120 15 T6 140 25 315 2 2 68 64 66 70 
7 45 1 50 163 1 HER 90 10 T6 150 20 320 3 3 68 70 70 66 
8 24 1 68 155 1 HER 75 10 T6 130 20 280 2 2 74 76 74 68 
9 54 1 80 170 1 HER 75 12 T6 160 15 320 3 3 82 78 76 78 
10 37 1 62 156 1 HER 100 12 T5 130 22 210 2 2 90 86 80 76 
11 32 1 52 160 1 HER 75 10 T6 140 15 300 3 3 78 68 70 76 
12 36 1 45 164 1 HER 75 12 T8 150 20 280 2 2 84 80 78 76 
13 26 1 50 168 1 HER 70 10 T6 160 20 310 2 2 86 78 70 66 
14 34 1 65 154 1 HER 75 12 T6 150 20 260 3 3 73 76 74 70 
15 32 1 68 168 1 HER 60 10 T6 160 20 250 2 2 88 82 76 70 
16 43 1 70 164 1 HER 70 15 T8 160 25 210 2 2 68 66 58 56 
17 44 2 55 159 2 VH 130 10 T6 140 25 240 3 3 68 66 56 54 
18 34 2 46 147 1 HER 60 15 T6 150 20 280 2 2 76 70 60 56 
19 52 2 62 152 2 VH 140 12 T6 140 30 220 3 2 80 72 69 62 
20 56 1 59 157 2 HER 75 10 T6 110 20 290 2 2 86 82 76 70 
21 45 1 70 165 2 VH 130 14 T6 100 25 300 2 2 88 92 78 70 
22 38 1 64 156 1 HER 75 12 T6 110 30 380 2 2 72 80 74 67 
23 34 1 55 158 1 TIBIA 100 12 T6 170 25 280 2 2 80 76 74 69 
24 52 2 58 167 2 VH 110 14 T6 110 30 310 3 3 76 74 70 65 
25 35 1 68 170 1 HER 60 12 T6 140 30 260 2 2 66 78 89 75 
26 48 1 63 162 2 VH 110 16 T8 120 30 300 2 2 82 96 88 68 
27 50 2 72 156 1 HER 70 10 T6 150 20 200 2 2 86 90 76 74 
28 39 1 78 155 2 VH 120 12 T6 110 25 260 3 2 78 88 74 72 
29 27 1 59 160 1 POP 70 12 T6 130 20 320 2 3 80 65 66 0 
30 48 2 50 154 1 VH 20 12 T6 160 25 200 2 2 70 68 58 54 
31 48 1 68 167 2 VH 110 16 T8 120 25 220 3 2 70 65 89 72 
32 38 1 63 170 1 HER 70 10 T6 150 20 320 2 3 80 68 88 70 
33 34 2 72 162 2 VH 120 12 T6 110 25 280 2 2 78 88 66 68 
34 52 2 78 156 1 POP 70 12 T6 130 20 300 3 2 86 90 74 74 
35 35 1 59 155 1 VH 20 12 T6 160 30 260 2 3 82 88 58 75 
 HR20 HR25 HR30 HR40 HR50 HR60 HR70 HR80 HR90 HR100 HR110 HR120 MAP0 MAP5 MAP10 MAP15 MAP20 MAP25 
55 52 52 50 56 58 56 60 58 68 56 55 100 71 65 65 71 69 
72 74 73 71 70 66 72 68 66 68 62 61 87 78 79 72 70 66 
66 61 54 56 55 51 55 57 55 52 54 55 79 74 83 74 71 73 
66 60 48 60 64 62 64 64 63 62 64 62 87 84 88 77 75 72 
72 68 64 60 64 62 62 56 65 53 60 54 82 79 46 76 73 77 
65 60 58 54 50 66 64 66 63 64 64 52 93 91 87 83 82 79 
64 64 66 60 58 56 62 56 64 62 62 60 81 81 77 77 74 71 
68 70 68 66 68 64 62 62 56 56 54 58 86 82 81 80 75 75 
76 68 66 62 60 56 58 54 65 52 56 54 84 84 81 75 76 74 
70 66 65 60 64 68 64 62 60 58 56 60 91 91 87 85 81 81 
72 68 62 60 58 56 60 58 54 62 72 68 79 78 87 85 81 72 
72 70 70 68 66 62 60 64 52 60 60 62 97 95 89 90 86 86 
66 64 60 60 58 57 55 55 55 52 54 55 80 79 77 79 75 75 
76 70 66 68 65 63 61 58 56 55 55 52 84 79 77 76 73 73 
60 55 54 55 53 52 50 52 52 55 52 53 89 79 78 75 72 71 
55 52 52 53 53 48 76 72 68 68 68 54 89 82 75 71 70 69 
52 47 70 64 60 56 56 58 54 54 54 54 85 78 76 75 70 70 
52 50 68 66 60 57 56 54 58 52 53 52 96 95 88 82 79 77 
56 53 54 62 52 54 50 53 53 53 53 52 96 92 91 89 88 83 
64 54 60 64 63 63 62 63 46 53 63 62 97 95 89 83 79 79 
66 54 64 60 56 52 54 57 50 58 62 62 89 88 84 79 77 75 
64 62 56 58 58 54 58 64 58 58 58 58 87 83 79 75 72 71 
68 60 58 54 50 68 58 45 52 68 54 64 93 87 83 79 75 70 
58 58 56 58 55 55 55 54 72 70 78 72 83 77 76 71 70 71 
70 68 65 64 64 64 62 62 50 62 60 58 82 77 74 75 70 70 
72 70 56 62 62 63 83 64 50 50 58 53 90 84 81 77 72 71 
66 66 64 54 54 52 72 53 64 50 44 43 86 85 76 73 72 73 
66 64 62 60 60 56 56 68 52 55 54 52 92 85 78 70 70 71 
56 52 52 78 72 68 60 56 42 52 46 58 90 85 76 75 72 73 
55 58 52 50 78 58 56 58 53 52 52 52 96 96 88 82 77 78 
72 70 62 50 62 56 56 58 50 50 53 58 82 77 88 75 77 70 
66 66 52 78 54 68 60 56 64 50 43 44 90 84 76 70 72 71 
66 64 64 60 60 56 56 58 52 55 52 54 86 85 78 73 70 73 
56 52 56 54 72 52 72 58 42 52 58 46 92 85 76 77 72 78 
55 58 52 62 78 68 83 68 53 52 52 52 90 96 81 75 72 70 
MAP30 MAP40 MAP50 MAP60 MAP70 MAP80 MAP90 MAP100 MAP110 MAP120 BRADYC HYPOTEN NAUSEA VOMITING OTHERS 
70 74 77 80 81 82 85 84 83 82 0 1 0 0 0 
67 74 66 68 63 57 54 65 68 67 1 1 0 0 0 
69 71 75 72 73 72 71 76 71 71 0 0 0 0 
 
70 72 83 89 87 86 86 85 87 86 1 0 0 0 
 
71 73 77 75 75 78 77 74 71 73 1 1 0 0 0 
79 79 81 77 78 77 77 77 75 76 1 0 0 0 
 
70 71 71 49 73 71 75 73 73 71 0 0 0 0 0 
77 73 74 72 71 71 68 69 66 69 0 1 0 0 0 
73 70 68 67 67 69 73 73 72 71 1 1 0 0 0 
81 79 72 70 71 70 67 65 67 65 1 1 0 0 dry mouth 
73 69 69 70 74 73 76 74 76 73 1 0 0 0 0 
88 79 74 79 77 74 75 73 73 70 0 1 0 0 0 
71 69 68 69 65 66 74 72 72 74 1 0 0 0 0 
70 67 65 63 77 73 73 72 71 71 0 1 0 0 0 
69 69 66 70 65 67 67 74 78 74 1 1 0 0 0 
65 65 67 71 68 76 75 75 71 71 1 0 0 0 0 
70 67 65 63 64 60 64 67 70 74 1 1 0 0 0 
82 79 79 80 77 76 77 73 70 69 1 1 0 0 0 
83 79 49 76 76 71 73 71 71 70 0 0 0 0 0 
76 73 75 71 66 77 79 77 77 76 1 0 0 0 dry mouth 
72 70 66 63 71 73 71 71 70 69 0 0 0 0 0 
69 67 69 71 70 69 70 70 73 69 0 1 0 0 0 
68 67 64 68 68 70 71 71 73 70 1 0 0 0 0 
70 68 68 69 67 69 74 71 69 74 1 0 0 0 0 
69 69 68 72 57 71 71 65 69 72 0 0 0 0 0 
69 72 70 68 69 69 68 69 70 70 1 0 0 0 0 
70 68 68 68 73 71 69 67 72 79 0 0 0 0 0 
69 68 68 69 67 69 68 65 68 72 1 1 0 0 0 
72 69 69 73 67 67 68 70 72 70 0 0 0 0 0 
76 73 73 69 73 69 71 70 70 72 0 1 0 0 0 
72 69 69 69 69 75 68 69 72 72 1 1 0 0 0 
76 68 68 72 67 71 68 67 68 70 0 0 0 0 0 
69 73 70 73 73 67 69 65 72 72 0 0 0 0 0 
70 69 68 68 67 71 71 70 70 79 1 1 0 0 0 
69 72 73 73 57 69 68 65 69 72 0 0 0 0 0 
GROUP II 
Sl. No AGE GENDER WEIGHT HEIGHT ASA SURGERY DURATION T10 PEAK 2DERM MG_3 DURATION SE_10 SED_END HR0 HR5 HR10 HR15 
1 40 2 70 160 2 VH 110 10 T6 165 25 295 3 3 100 96 93 87 
2 35 2 45 170 1 VH 100 6 T6 140 25 360 3 3 82 89 82 62 
3 55 1 52 158 1 HER 80 8 T6 160 25 330 3 3 64 62 62 60 
4 58 1 60 164 1 HER 75 12 T5 180 20 300 4 3 66 89 87 65 
5 35 1 60 162 1 HER 70 8 T5 150 20 300 3 3 74 76 64 58 
6 22 1 48 156 1 TIBIA 60 10 T6 180 20 260 3 3 53 54 53 50 
7 49 1 68 162 1 HER 80 8 T5 155 20 330 4 3 86 84 74 70 
8 40 1 64 166 1 HER 70 6 T5 160 20 345 3 3 70 68 65 65 
9 43 1 50 160 1 HER 90 8 T5 150 25 320 3 3 82 80 76 68 
10 44 2 52 155 1 VH 120 8 T6 150 25 300 4 3 68 62 65 64 
11 43 1 64 164 1 HER 60 6 T5 160 35 380 4 4 78 78 70 66 
12 45 1 54 168 1 HER 70 6 T5 150 15 340 4 4 72 72 72 72 
13 45 1 56 158 2 HER 120 10 T6 140 30 280 3 3 84 82 80 74 
14 36 2 44 162 2 VH 110 6 T5 160 15 340 4 3 74 70 66 66 
15 55 1 44 160 1 VH 120 8 T6 180 25 320 3 3 62 54 50 50 
16 54 1 55 166 2 VH 130 10 T6 160 20 300 4 3 80 64 66 56 
17 52 2 56 154 1 VH 120 8 T5 130 20 320 4 3 86 78 76 72 
18 55 2 55 150 1 VH 110 10 T8 140 25 290 3 3 88 80 68 68 
19 45 2 60 158 1 VH 140 12 T5 180 20 310 3 3 84 88 69 73 
20 48 2 48 148 1 VH 120 10 T6 160 20 330 3 3 92 84 88 72 
21 29 1 54 158 1 HER 70 6 T6 200 20 400 3 3 60 64 58 55 
22 36 1 63 168 1 HER 60 8 T6 170 25 280 4 3 74 82 74 68 
23 56 2 54 152 1 VH 120 8 T6 180 25 310 3 3 92 88 64 60 
24 54 1 60 166 1 HER 75 8 T6 160 20 280 4 3 86 74 76 73 
25 50 2 62 102 1 VH 110 8 T6 170 25 310 4 3 82 86 68 66 
26 45 2 70 172 2 HER 70 10 T6 160 25 330 3 3 88 90 80 64 
27 48 1 68 154 2 HER 90 8 T5 150 20 280 3 3 84 78 72 68 
28 32 1 74 164 1 HER 100 12 T6 160 25 320 3 3 90 84 80 78 
29 47 1 57 106 1 HER 90 8 T5 180 30 340 3 3 92 85 76 70 
30 57 2 58 156 2 VH 120 10 T6 150 25 310 3 3 78 74 64 63 
31 57 2 57 172 1 VH 120 8 T6 180 25 330 4 3 90 88 64 80 
32 47 1 58 154 1 HER 75 8 T6 160 20 280 4 3 78 84 68 72 
33 32 1 74 164 1 VH 110 8 T6 170 25 320 3 3 84 90 78 80 
34 48 1 68 106 2 HER 70 10 T6 160 25 340 3 3 85 92 70 76 
35 45 2 70 156 1 HER 90 8 T5 150 20 310 3 3 74 78 63 64 
HR20 HR25 HR30 HR40 HR50 HR60 HR70 HR80 HR90 HR100 HR110 HR120 GROUP MAP0 MAP5 MAP10 MAP15 MAP20 MAP25 
83 82 82 82 80 79 78 78 77 86 84 64 2 93 75 72 74 72 71 
59 58 57 56 55 54 55 57 55 56 58 58 2 90 100 90 76 71 72 
56 53 50 48 47 54 55 56 54 55 58 55 2 111 100 96 87 82 78 
65 64 63 63 63 60 57 59 57 58 56 57 2 107 92 72 90 84 84 
54 54 54 52 51 51 48 55 60 61 62 64 2 109 95 85 83 80 78 
54 52 46 52 57 56 57 58 56 57 56 55 2 79 74 76 64 67 65 
68 63 65 62 60 61 58 57 58 56 59 55 2 97 87 71 69 66 70 
68 64 62 60 57 50 59 61 58 58 59 57 2 113 99 93 85 79 79 
61 55 48 56 58 63 57 56 59 57 58 59 2 92 87 74 74 70 68 
66 62 60 56 58 56 55 52 50 48 56 68 2 91 88 91 89 88 75 
72 58 56 56 54 52 54 55 52 52 53 47 2 88 92 88 83 79 73 
74 74 70 62 64 62 62 60 62 60 60 56 2 93 90 84 83 81 79 
74 68 68 70 68 68 64 64 62 60 60 60 2 97 79 83 67 63 58 
62 60 56 58 56 56 53 52 54 54 52 54 2 86 83 79 81 78 73 
50 50 46 54 54 56 54 54 54 53 53 52 2 89 87 82 67 69 69 
54 52 52 52 53 54 52 52 52 50 50 52 2 91 85 93 92 95 87 
60 64 66 60 58 56 54 56 53 52 50 52 2 91 89 88 88 88 88 
67 66 62 62 60 61 65 65 61 56 56 54 2 88 85 74 76 71 68 
67 69 70 66 64 60 62 62 58 59 58 58 2 88 79 77 69 63 61 
70 66 66 68 59 60 60 62 56 59 55 65 2 95 84 87 79 73 73 
53 51 52 47 64 64 64 63 62 62 63 63 2 95 89 84 79 77 68 
58 56 56 54 52 55 56 56 57 57 58 57 2 91 85 79 78 78 74 
54 54 52 52 46 67 66 63 65 63 62 63 2 90 84 81 76 73 71 
68 67 66 59 58 55 56 56 56 57 63 64 2 99 91 83 80 78 77 
62 57 54 52 49 73 58 55 56 56 58 58 2 85 77 73 73 72 70 
64 65 58 55 55 55 53 54 54 55 56 55 2 101 93 83 81 77 73 
60 58 56 55 54 54 52 52 64 62 60 62 2 93 90 78 77 73 71 
58 56 55 56 57 56 55 56 54 57 58 58 2 85 5 78 79 76 73 
64 62 55 52 45 68 60 60 59 56 58 58 2 58 85 62 78 74 72 
62 62 57 60 56 55 55 54 56 55 55 56 2 83 78 75 77 73 73 
65 64 55 58 55 55 54 53 55 54 55 56 2 83 77 78 77 81 71 
58 60 55 56 54 54 52 52 62 64 62 60 2 58 93 78 73 77 65 
56 58 56 55 56 57 56 55 57 54 58 58 2 85 90 81 76 79 77 
62 64 52 55 68 45 60 60 56 59 58 58 2 93 77 83 74 78 69 
62 62 60 57 55 56 54 55 55 56 56 55 2 93 85 73 73 77 69 
 
MAP30 MAP40 MAP50 MAP60 MAP70 MAP80 MAP90 MAP100 MAP110 MAP120 BRADYC HYPOTEN NAUSEA VOMITING OTHERS 
63 64 65 62 74 73 71 72 73 71 0 1 0 0 0 
72 71 72 73 70 71 71 71 74 73 1 0 0 0 0 
73 65 63 75 87 85 85 85 82 85 1 1 0 0 DRY MOUTH 
81 82 81 81 81 81 75 77 74 73 0 1 0 0 0 
79 76 79 83 84 83 88 91 92 94 1 1 0 0 0 
65 65 71 80 79 77 76 79 78 77 0 1 0 0 0 
71 71 70 73 74 73 71 70 71 71 1 1 0 0 0 
76 72 71 69 71 66 65 69 68 70 1 0 0 0 0 
67 70 71 72 74 73 72 71 70 74 1 0 0 0 0 
75 71 70 73 69 70 67 66 63 78 0 1 0 0 0 
71 73 73 73 73 78 78 73 69 69 1 0 0 0 0 
81 81 84 81 81 81 79 78 77 73 0 0 0 0 0 
60 70 67 64 83 79 79 76 78 78 0 1 0 0 0 
75 73 75 73 71 69 69 67 36 67 1 0 0 0 0 
65 69 71 68 68 66 66 67 66 69 1 1 0 0 0 
85 86 89 93 92 89 82 86 88 88 1 0 0 0 0 
89 83 84 80 81 82 82 82 79 76 1 0 0 0 0 
76 79 75 75 74 74 74 74 73 71 1 1 0 0 0 
67 67 71 73 73 80 74 71 69 69 0 1 0 0 0 
72 69 71 66 72 69 68 73 69 69 1 0 0 0 0 
69 67 65 72 71 73 71 71 72 73 1 1 0 0 0 
72 69 67 58 78 77 74 72 72 73 0 1 0 0 0 
69 69 66 67 69 71 71 70 70 71 1 0 0 0 0 
70 73 73 71 74 71 71 70 72 75 1 1 0 0 0 
69 69 67 65 70 71 70 69 69 71 1 0 0 0 0 
71 72 72 67 68 67 67 70 69 71 0 1 0 0 0 
65 67 59 74 78 77 75 71 71 72 1 1 0 0 0 
77 72 69 67 70 68 68 70 68 70 1 0 0 0 0 
69 68 68 66 70 70 67 69 72 74 1 0 0 0 0 
69 67 67 69 69 71 72 68 71 78 0 0 0 0 0 
73 72 72 68 68 67 67 69 70 71 0 1 0 0 0 
71 59 67 78 78 75 77 71 71 72 1 1 0 0 0 
73 69 72 70 70 68 68 68 70 70 1 0 0 0 0 
72 68 68 70 70 67 70 72 69 74 1 0 0 0 0 
73 67 67 69 69 72 71 71 68 78 0 0 0 0 0 
 
